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Abstract 
Amine oxidases catalyse the oxidative degradation of amines into 
the corresponding aldehyde, ammonia and hydrogen peroxide. 
They can be classified into different subfamilies based on the 
prosthetic group: (1) proteins with flavin adenine dinucleotide 
(FAD) make the FAD-dependent amine oxidase subfamily, which 
include monoamine oxidases (MAO) and polyamine oxidases 
(PAO) and (2) proteins with copper and quinocofactor make the 
other subfamily, which includes the copper-dependent amine 
oxidase (CAO) that have topaquinone (TPQ) as cofactor and the 
lysyl oxidases (LOX) that have the lysyl tyrosylquinone (LTQ) 
cofactor.  
Most mammals have four CAO genes, each encoding a protein 
with a different function and substrate preference. The 
phylogenetic study with CAOs showed that these proteins can be 
classified into different subfamilies based on the conserved active 
site motif, X1-X2-Asn-Tyr-Asp. This classification is consistent 
with the different substrate preferences known for these proteins. 
Residue X2 can be used to distinguish AOC1 (X2=Tyr, diamine 
preference), AOC2 (X2=Gly, aromatic monoamine preference) 
and AOC3/4 (X2= Leu, aliphatic monoamine preference). The 
phylogenetic analysis led us to develop a novel classification 
system for the AOC3 and AOC4 proteins. These proteins can be 
classified based on the X1 residue from the motif, which is Leu in 
AOC3 and Met in AOC4. 
When the N-glycosylations in hAOC1 were studied, it was found 
that the Asn110 site mainly contained oligomannosidic glycans. 
This site seems to be conserved in vertebrate CAOs and in 
hAOC1 it is located in a hydrophobic cleft on the surface. The 
attached glycans play a role in the correct folding, stabilization of 
the D2 domain, and protein secretion. Due to the high degree of 
conservation in the glycan composition, this N-glycosylation site 
likely plays a similar role in hAOC3 and porcine AOC1. The N-
glycosylation sites at Asn168, Asn538 and Asn745 play a role in 
protein segregation and folding, and the Asn538 and Asn745 
located near the inter-monomeric arms seem to be important for 
the dimer stability. 
The interaction between hAOC3 and its leucocyte counter 
receptor, Siglec-9, is powerful tool for in vivo visualization of 
inflammation. In this thesis, the interactions between hAOC3 and 
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cofactor.  
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with a different function and substrate preference. The 
phylogenetic study with CAOs showed that these proteins can be 
classified into different subfamilies based on the conserved active 
site motif, X1-X2-Asn-Tyr-Asp. This classification is consistent 
with the different substrate preferences known for these proteins. 
Residue X2 can be used to distinguish AOC1 (X2=Tyr, diamine 
preference), AOC2 (X2=Gly, aromatic monoamine preference) 
and AOC3/4 (X2= Leu, aliphatic monoamine preference). The 
phylogenetic analysis led us to develop a novel classification 
system for the AOC3 and AOC4 proteins. These proteins can be 
classified based on the X1 residue from the motif, which is Leu in 
AOC3 and Met in AOC4. 
When the N-glycosylations in hAOC1 were studied, it was found 
that the Asn110 site mainly contained oligomannosidic glycans. 
This site seems to be conserved in vertebrate CAOs and in 
hAOC1 it is located in a hydrophobic cleft on the surface. The 
attached glycans play a role in the correct folding, stabilization of 
the D2 domain, and protein secretion. Due to the high degree of 
conservation in the glycan composition, this N-glycosylation site 
likely plays a similar role in hAOC3 and porcine AOC1. The N-
glycosylation sites at Asn168, Asn538 and Asn745 play a role in 
protein segregation and folding, and the Asn538 and Asn745 
located near the inter-monomeric arms seem to be important for 
the dimer stability. 
The interaction between hAOC3 and its leucocyte counter 
receptor, Siglec-9, is powerful tool for in vivo visualization of 
inflammation. In this thesis, the interactions between hAOC3 and 
a Siglec-9 derived peptide were analysed taking into account for 
the first time the glycosylations in hAOC3. The peptide binds in 
the active site of hAOC3 competing for the same binding site as 
semicarbazide and imidazole. Moreover, the predicted binding 
mode of the peptide is in accordance with PET studies using 
rodent, rabbit and pig AOC3 proteins.  
The polyamine oxidases (PAO) belong to the FAD-dependent 
amine oxidases. PAOs are involved in the catabolism of 
spermidine and their acetyl. The PAO from Synechocystis sp. PCC 
6803 (SynPAO) was characterized in this thesis. SynPAO is 
involved in the polyamine back-conversion pathway, with 
spermidine being the preferred substrate. The structural analysis 
together with the phylogenetic tree revealed that Gln94, Tyr403 
and Thr440 are predicted to be key residues in the active site to 
SynPAO. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sammanfattning  
Aminoxidaser katalyserar den oxidativa nedbrytningen av 
aminer till motsvarande aldehyd, ammoniak och väteperoxid. De 
kan klassificeras i olika underfamiljer baserat på den prostetiska 
gruppen: (1) proteiner med flavin-adenin-dinukleotid (FAD) 
utgör den FAD-beroende aminoxidas-underfamiljen med 
monoaminoxidaser (MAO) och polyaminoxidaser (PAO) och (2) 
proteiner med koppar och kino-kofaktor utgör den andra 
underfamiljen med kopparberoende aminoxidas (CAO) som har 
topakinon (TPQ) som kofaktor och lysyloxidaserna (LOX) som 
har lysyltyrosylkinon (LTQ). 
De flesta däggdjur har fyra CAO-gener, som alla kodar för ett 
protein med specifik funktion och substratpreferens. Den 
fylogenetiska studien med CAO visade att dessa proteiner kan 
klassificeras i olika underfamiljer baserat på det konserverade 
aminosyramönstret X1-X2-Asn-Tyr-Asp i det aktiva stället. 
Denna klassificering överensstämmer med de olika 
substratpreferenser som är kända för dessa proteiner. Aminosyra 
X2 kan användas för att skilja AOC1 (X2 = Tyr, diaminpreferens), 
AOC2 (X2 =Gly, aromatisk monoaminpreferens) och AOC3/4 
(X2 = Leu, alifatisk monoaminpreferens). På basen av den 
fylogenetiska analysen utvecklades ett nytt klassificeringssystem 
för AOC3- och AOC4-proteinerna. Dessa proteiner kan 
klassificeras baserat på X1-aminosyran från aminosyramönstret, 
som är Leu i AOC3 och Met i AOC4. 
Studierna av N-glykosyleringarna i hAOC1 visade att Asn110-
positionen huvudsakligen innehöll oligomannosidiska glykaner. 
Denna position verkar bevaras i vertebrat-CAO och i hAOC1 är 
den lokaliserad i en hydrofob klyfta på ytan. De bifogade 
glykanerna spelar en roll vid korrekt veckning, stabilisering av 
D2-domänen och proteinsekretion. På grund av den höga graden 
av konservation i glykankompositionen spelar denna N-
glykosyleringposition sannolikt en liknande roll i hAOC3 och 
gris AOC1. N-glykosyleringspositionerna vid Asn168, Asn538 
och Asn745 spelar en roll vid proteinsegregering och veckning, 
och Asn538 och Asn745, som är belägna nära de intermonomera 
armarna, verkar vara viktiga för dimerstabiliteten. 
Samspelet mellan hAOC3 och dess leukocytbindningspartner 
Siglec-9 är ett kraftfullt verktyg för in vivo visualisering av 
inflammation. I denna avhandling analyserades 
a Siglec-9 derived peptide were analysed taking into account for 
the first time the glycosylations in hAOC3. The peptide binds in 
the active site of hAOC3 competing for the same binding site as 
semicarbazide and imidazole. Moreover, the predicted binding 
mode of the peptide is in accordance with PET studies using 
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D2-domänen och proteinsekretion. På grund av den höga graden 
av konservation i glykankompositionen spelar denna N-
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och Asn745 spelar en roll vid proteinsegregering och veckning, 
och Asn538 och Asn745, som är belägna nära de intermonomera 
armarna, verkar vara viktiga för dimerstabiliteten. 
Samspelet mellan hAOC3 och dess leukocytbindningspartner 
Siglec-9 är ett kraftfullt verktyg för in vivo visualisering av 
inflammation. I denna avhandling analyserades 
samverkningarna mellan hAOC3 och en peptid härledd från 
Siglec-9 och för första gången beaktades glykosyleringarna på 
hAOC3. Peptiden binder till det aktiva stället hos hAOC3 där 
den konkurrerar med semikarbazid och imidazol om samma 
bindningsställe. Det förutspådda bindningssättet för peptiden 
stämmer dessutom överens med PET-studier där AOC3 från 
gnagare, kanin och gris har använts. 
Polyaminoxidaserna (PAO) hör till de FAD-beroende 
aminoxidaserna. PAO är involverade i katabolismen av 
spermidin och dess acetyl. PAO från Synechocystis sp. PCC 6803 
(SynPAO) karakteriserades i denna avhandling. SynPAO är 
involverat i polyaminers exo-omvandling och föredrar spermidin 
som substrat. Den strukturella analysen tillsammans med det 
fylogenetiska trädet visade att Gln94, Tyr403 och Thr440 kan vara 
viktiga aminosyror i det aktiva stället hos SynPAO. 
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3D   Three-dimensional 
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AOC2  Copper amine oxidase 2; alternative names: retina-specific amine  
  oxidase (RAO) 
AOC3  Copper amine oxidase 3; alternative names: vascular adhesion  
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  oxidase (SAO) 
AGAO  Arthrobacter globiformis amine oxidase 
AtPAO  Arabidopsis thaliana polyamine oxidase 
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BLAST   Basic Local Alignment Search Tool  
CAO   Copper amine oxidase 
CNX  Calnexin 
CRT   Calreticulin  
ECAO  Escherichia coli amine oxidase 
ER   Endoplasmic reticulum 
ERAD  Endoplasmic reticulum-associated protein degradation  
FAD   Flavin adenine dinucleotide 
Glc   D-Glucose  
GlCNAc  N-acetylglucosamine  
GnT1   N-acetyl-glucosaminyltransferase 1  
HPAO   Hansenula polymorpha amine oxidase 
HMM  Hidden Markov model   
HvPAO    Hordeum vulgare polyamine oxidase 
JTT   Jones Taylor Thornton 
LG   Le Gascuel 
LOX   Lysyl oxidase 
Man   D-Mannose  
MAO  Monoamine oxidase 
ML  Maximum likelihood 
Nac   D-glucosamine 
NCBI   National Center for Biotechnology Information 
NJ  Neighbour joining 
NMR  Nuclear Magnetic Resonance 
OsPAO  Oryza sativa polyamine oxidase 
PAO  Polyamine oxidase 
PCA   Principal component analysis  
PDB   Protein Data Bank 
PET   Positron emission tomography 
PPLO  Pichia pastoris amine oxidase 
PSAO  Pisum sativum amine oxidase 
Siglec  Sialic acid binding Immunoglobulin-like lectins 
SMO  Spermine oxidase 
SynPAO  Synechocystis sp. PCC 6803 polyamine oxidase 
TC  Terminal catabolism  
TPQ   2,4,5-trihydroxyphenylalanine quinone, topaquinone 
ZmPAO  Zea mays polyamine oxidase   
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1. Introduction 
 
Proteins are the engines of life. They are macromolecules that play a 
variety of roles in supporting all living organisms. There are twenty 
different amino acids that build the proteins and the genetic 
information stored in the DNA determines how the amino acids are 
assembled. The polypeptide chain of amino acids carries 
information that specifies how proteins fold into their three-
dimensional (3D) structure. For their function, proteins may also 
require cofactors that can be e.g. an inorganic group or an amino 
acid that has undergone a posttranslational modification. The 3D 
structure of a protein determines its function in which its ability to 
interact with other molecules or with other proteins has an 
important role. For example, proteins can function as hormones that 
transmit signals to coordinate biological processes (e.g. growth 
hormone) (Greenwood and Landon, 1966), they can help in the 
immune system by protecting our body against virus and bacteria 
(e.g. immunoglobulin G) (Mallery et al., 2010), they can have a 
structural role (e.g. actin) (Doherty and McMahon, 2008) and they 
also can work as enzymes (e.g. amine oxidases) (Mondovì and Agrò, 
1982). In general, enzymes are biocatalysts, which catalyse a specific 
reaction, and they can be classified as transferases, hydrolases, 
lyases, isomerases, ligases and oxidoreductases according to the 
catalysed reaction. For example, amine oxidases, which belong to 
oxidoreductases catalyse a variety of biological amines to their 
corresponding aldehyde and each amine oxidase subfamily has a 
preference for a certain amine. 
In the 1960s decade computers emerged to be an important tool in 
biological research (Hagen, 2000). The increasing number of 
available amino and nucleic acid sequences and the idea that 
macromolecules carry information together with high-speed 
computers united biology and information technology (Hagen, 2000; 
Luscombe et al., 2001), to create bioinformatics. Bioinformatics aims 
to organize data allowing researchers to easily access data, to 
develop tools and resources for data analysis and to use those tools 
to analyse the data in a biologically meaningful way (Luscombe et 
 7 
al., 2001). Based on the source of information, bioinformatics can be 
divided into two classes: sequence based and structure based 
(Choong et al., 2013). Data analysis of genomes, sequence 
alignments, phylogenetic analysis and identification of motifs are 
examples of sequence based bioinformatics (Choong et al., 2013; 
Luscombe et al., 2001). Structure based bioinformatics is related to 
the analysis of 3D structure of proteins, structure based alignments, 
molecular simulations (docking predictions and molecular 
dynamics) and intermolecular interactions (Choong et al., 2013; 
Luscombe et al., 2001). The two classes of bioinformatics are closely 
linked and commonly used in an integrative manner.   
Combining the 3D structure of a protein (X-ray crystallography, 
NMR and homology modelling) with data about the protein’s 
function (experimental data and different databases), occurrence in 
different genomes (homologous sequences, sequence alignments 
and phylogenetic analyses) and the interactions with other 
molecules (protein-protein interactions, docking simulations and 
molecular dynamics) integrates the information and puts in it a 
meaningful biological context (Gerstein, 2000). The work described 
throughout this thesis explores an integrative data analysis 
approach. Structural and sequence data, functional information, 
genome occurrence and molecular interactions were used together 
to characterize mammalian copper amine oxidases and one 
cyanobacteria polyamine oxidase. 
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2. Review of the literature 
2.1. Amine oxidases 
Amine oxidases (AO) are a family of proteins found in all living 
organisms, they are diverse in terms of structure, catalytic and 
substrate oxidation mechanisms (Toninello et al., 2006). AO catalyse 
the oxidative degradation of amines into the corresponding 
aldehyde, ammonia and hydrogen peroxide (Figure 1). These 
proteins can be classified into two distinct classes based on their 
prosthetic group: (1) the flavin adenine dinucleotide (FAD)-
dependent AOs and (2) the copper-dependent AOs. 
 
Figure 1. General reaction catalysed by amine oxidases. 
The FAD-dependent AOs include two mitochondrial monoamine 
oxidases (MAO A and MAO B; EC 1.4.3.4) and the cytosolic 
polyamine oxidase (PAO; EC 1.5.3.17). MAOs metabolize 
neurotransmitters and MAO inhibitors are used to treat depression, 
anxiety disorders, Parkinson and Alzheimer´s disease (Yamada and 
Yasuhara, 2004). PAOs are involved in the catabolism of spermine, 
spermidine and their acetyl derivatives at their secondary amino 
group (Cona et al., 2006).   
The copper-dependent AOs can be further classified based on their 
quinone cofactor. In the copper amine oxidases (CAOs, EC 1.4.3.21 
and EC 1.4.2.22) the cofactor is 2,4,5-
trihydroxyphenylalaninequinone (TPQ), whereas in the lysyl 
oxidases (LOXs, EC 1.4.3.13) the cofactor is lysine tyrosylquinone 
(LTQ) (Klinman, 1996). The LOX enzymes convert lysine and 
hydrxyolysine residues in collagens and elastin into highly reactive 
aldehydes, having a role in the remodelling of the extracellular 
matrix (Grau-Bové et al., 2015). Humans have five members of the 
LOX family, which are divided into two subgroups based on the N-
terminal domain: the LOX and LOX1 form one subgroup and LOX2, 
LOX3 and LOX4 the other subgroup (Finney et al., 2014). CAOs are 
divided into several subclasses with different tissue and substrate 
 9 
preference and they oxidize the primary amino group of the amine 
substrates (Cona et al., 2006; Finney et al., 2014). This thesis focuses 
on two AO families, CAOs and PAOs, which are described in detail 
in the following sections.  
2.2. Polyamine oxidases  
2.2.1. Function and catalytic reaction  
Polyamines are positively charged molecules present in all 
prokaryotic and eukaryotic cells. The most common polyamines are 
putrescine, spermidine and spermine. They are involved in cell 
growth, development and adaptation against environmental stress 
(Bouchereau et al., 1999; Cona et al., 2006; Tavladoraki et al., 2016). 
One of the potential uses of PAOs is as biosensors, to detect 
biogenetic amines for food analysis and human diagnostics (Boffi et 
al., 2015). PAOs are FAD-dependent AO that catalyse the oxidation 
of polyamines via an oxidative cleavage of the α-CH bond of the 
substrate to form an imine product with associated reduction of the 
non-covalently bound FAD cofactor (Figure 2A). The imine product 
is non-enzymatically hydrolysed to the corresponding aldehyde and 
ammonia or amine (for secondary or tertiary amine substrates), the 
reduced FAD cofactor reacts with oxygen forming hydrogen 
peroxide and re-oxidizing the cofactor, completing the catalytic cycle 
(Binda et al., 2001) (Figure 2A). The differences in the reaction 
products reflect the differences in the position and orientation of the 
substrate inside the catalytic site.  
In plants, two types of PAOs have been identified: (1) proteins that 
oxidase the carbon on the endo-site of the N5-nitrogen (terminal 
catabolic pathway) and (2) proteins that oxidize the carbon on the 
exo-site of the N5-nitrogen (back-conversion pathway) (Figure 2B). 
PAO from Zea mays (maize; ZmPAO), an Oryza sativa PAO (rice; 
OsPAO7) and two Hordeum vulgare PAOs (barley; HvPAO1 and 
HvPAO2) are involved in the terminal catabolic pathway (Cervelli et 
al., 2006; Liu et al., 2014a; Tavladoraki et al., 1998). They oxidize 
spermidine and spermine to produce 4-aminobutanal and N-(3-
aminopropyl)-4-aminobutanal, respectively (Figure 2B). Arabidopsis 
thaliana PAOs (AtPAO1-5), several O. sativa PAOs (OsPAO1, 
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PAO from Zea mays (maize; ZmPAO), an Oryza sativa PAO (rice; 
OsPAO7) and two Hordeum vulgare PAOs (barley; HvPAO1 and 
HvPAO2) are involved in the terminal catabolic pathway (Cervelli et 
al., 2006; Liu et al., 2014a; Tavladoraki et al., 1998). They oxidize 
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aminopropyl)-4-aminobutanal, respectively (Figure 2B). Arabidopsis 
thaliana PAOs (AtPAO1-5), several O. sativa PAOs (OsPAO1, 
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OsAO4-5), animal and yeast PAOs are involved in the back-
conversion pathway (Ahou et al., 2014; Cervelli et al., 2015; Cona et 
al., 2006; Fincato et al., 2011; Liu et al., 2014a; Ono et al., 2012). These 
proteins oxidize spermine to spermidine and/or spermidine to 
putrescine (Figure 2B).  
 
 
Figure 2. A: ZmPAO reaction scheme for spermine oxidation (adapted from Binda 
et al., 2001). B: Schematic representation of spermine and spermidine oxidation by 
PAOs. Arrowheads B or T indicate the oxidised carbon atoms in the back 
conversion or terminal conversion, respectively (adapted from Fincato et al., 2011). 
2.2.2. The PAO fold 
The 3D structure of the ZmPAO is solved both in native state (Binda 
et al., 1999) and in complex with spermidine and spermine (Fiorillo 
et al., 2011). The structure of ZmPAO is composed of two domains, a 
FAD-binding domain and a substrate-binding domain (Figure 3A). 
The interface between the domains forms a 30Å long U-shaped 
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tunnel that defines the active centre (Binda et al., 1999) (Figure 3B). 
The structure of yeast PAO (Fms1) is also known in the native form 
and in complex with spermine (Huang et al., 2005).  
Despite having only 20% sequence identity, Fms1 and ZmPAO have 
a similar fold. Although both proteins have several common 
features, their structures revealed important differences (Fiorillo et 
al., 2011) e.g. the isoaloxazine ring of the cofactor is planar in Fms1 
but bent in ZmPAO and some of the key residues in the active site 
are not totally conserved. As a result of these differences, Fms1 has a 
more hydrophobic substrate-binding site compared to that of 
ZmPAO. The binding of spermine is also different in both proteins. 
In Fms1 spermine binds more shallowly in the tunnel, with the C6 
atom too far from the N5 of FAD to allow the production of 3-
(aminopropyl)4-aminobutyraldehyde and 1,3-diaminopropane, but 
the C4 is close enough to N5 of FAD to produce spermidine and 3-
aminopropanal. In ZmPAO, spermine binds deep inside of the 
tunnel and the C6 atom is positioned closer to FAD whereas the C4 is 
further away. These differences are responsible for the differences 
between the endo- and exo-mode of oxidation.  
 
Figure 3. A: The PAO fold, orange ribbons represent the catalytic domain and white 
ribbons the FAD binding domain. FAD cofactor is shown as white ball and stick 
representation. B: Surface view showing the entrances of the U-shaped active site 
tunnel highlighted with boxes with the PAO fold in orange and §the catalytic 
domain in white colour.  
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Figure 2. A: ZmPAO reaction scheme for spermine oxidation (adapted from Binda 
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2.2.2. The PAO fold 
The 3D structure of the ZmPAO is solved both in native state (Binda 
et al., 1999) and in complex with spermidine and spermine (Fiorillo 
et al., 2011). The structure of ZmPAO is composed of two domains, a 
FAD-binding domain and a substrate-binding domain (Figure 3A). 
The interface between the domains forms a 30Å long U-shaped 
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2.3. Copper amine oxidases  
Humans have three CAOs: (1) human diamine oxidase (AOC1), (2) 
retina-specific CAO (AOC2) (3) human vascular adhesion protein-1 
(AOC3). Some mammals also contain an additional soluble CAO 
(AOC4), however, humans have a non-functional AOC4 protein due 
to a stop codon (Schwelberger, 2010). Rodents are also missing the 
AOC4 protein, since they only have small fragments of the AOC4 
gene (Schwelberger, 2007). Moreover, rat is missing the AOC2 gene 
(Zhang et al., 2003). In general, organisms with high levels of plasma 
CAO have the AOC4 gene (Schwelberger, 2010). Despite having 
highly similar structures (reviewed in 2.3.5) all mammalian CAOs 
have different function and different substrate preferences (Bonaiuto 
et al., 2010; Finney et al., 2014).  
2.3.1. AOC1 
Human AOC1 is a soluble protein involved in the degradation of 
exogenous histamine mainly expressed in kidney, placenta, intestine 
and seminal vesicles (Elmore et al., 2002). It has been suggested to 
have functions related with cell proliferation, inflammation, allergic 
response and ischemia (McGrath et al., 2009). Decreased levels of 
hAOC1 have been linked with histamine intolerance (Maintz and 
Novak, 2007). There is also evidence that some pharmaceuticals 
might interfere with normal AOC1 function and cause harmful side 
effects (Maintz and Novak, 2007; McGrath et al., 2009; Sattler et al., 
1985). The plasma concentrations of AOC1 increase several 
hundred-fold during pregnancy and low AOC1 concentrations 
increase the risk of premature pregnancy termination by 17-fold 
(Maintz et al., 2008).  AOC1 has preference for diamines such as 
histamine and its methylated form (1-methylhistamine) (Elmore et 
al., 2002).  
 
2.3.2. AOC2 
Imamura and co-workers cloned AOC2 from human retina in 1997 
(Imamura et al., 1997). To date a lot remains to be discovered about 
this protein, which is the least studied human CAO. AOC2 mRNA 
has been found in different tissues (lung, brain, kidney, cartilage, 
tonsil and heart) but enzyme activity was only found in retina 
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(Kaitaniemi et al., 2009). AOC2 preferably oxidises aromatic 
monoamines in vitro and it has shown activity towards 2-
phenylethyamine, tryptamine, p-tyramine (Kaitaniemi et al., 2009).  
 
2.3.3. AOC3 
The AOC3 protein is primarily expressed under inflammatory 
conditions on the endothelial cell surface but it is also found in 
muscle cells and adipocytes (Jaakkola et al., 1999; Salmi et al., 1993; 
Zorzano et al., 2003). It is a dual function protein, working as an 
amine oxidase and as an adhesion molecule involved in leucocyte 
trafficking (Salmi and Jalkanen, 2001). Both functions are linked 
(Noonan et al., 2013), as the amine oxidase reaction products change 
the expression of some endothelial selectins involved in the 
leucocyte extravasation cascade (Jalkanen et al., 2007). In adipocytes, 
the suggested roles for AOC3 are related to glucose metabolism 
(Boomsma et al., 2005) and defence against subcutaneous bacterial 
infiltration (Shen et al., 2012). AOC3 activity in adipocytes has been 
shown to be down regulated by hypoxia (Repessé et al., 2015). AOC3 
is a membrane bound protein, but it can be proteolytically cleaved to 
a soluble form in the blood (sAOC3, serum AOC3) (Abella et al., 
2004; Kurkijärvi et al., 1998; Stolen et al., 2004). The substrates of 
AOC3 include the physiological amines methylamine and 
aminoacetone and benzylamine functions as an in vitro substrate 
(Shen et al., 2012). Recently, the leukocyte surface proteins Siglec 
(sialic acid-binding Immunoglobulin (Ig)-like lectin) -9 and -10 were 
identified as a counter-receptors for human AOC3 (hAOC3) (Aalto 
et al., 2011; Kivi et al., 2009). Moreover, the interaction mechanism 
between hAOC3 and Siglec-9 has been characterized (Aalto et al., 
2011; Elovaara et al., 2016).   
2.3.4. AOC4  
AOC4 is a soluble plasma protein expressed in the liver and secreted 
into the bloodstream, making it the major serum amine oxidase in 
some mammalian species (Schwelberger, 2006). Bovine AOC4 
(bAOC4) is the most studied AOC4 protein. The physiological 
polyamines spermidine and spermine, long hydrophobic amines 
and also benzylamine with hydrophobic substituents are the 
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preferred substrates for AOC4 (Bonaiuto et al., 2010; Di Paolo et al., 
2003). 
2.4. TPQ and the reaction mechanisms of CAOs  
CAOs catalyse two different reactions: (1) an autocatalytic reaction 
that gives origin to TPQ and requires molecular oxygen and copper 
to occur (Figure 4A) and (2) the catalytic reaction converting 
primary amines to the corresponding aldehydes (Figure 4B). The 
catalytic reaction is divided into the reductive half-reaction and the 
oxidative half-reactions. TPQ, which was first identified by Janes et 
al. in 1990 (Janes et al., 1990) derives from a post-translationally 
modified tyrosine (Mure, 2004). The modified Tyr is part of a 
specific motif, Thr-X1-X2-Asn-Tyr-Asp (Parsons et al., 1995), 
hereafter referred as the active site motif. The relevancy of the 
conserved residues in the motif has been assessed by mutational 
studies (Choi et al., 1996). TPQ is buried inside the active site near 
the copper-binding site.  It is quite mobile as it can flip around the 
χ2 and χ1 angles interchanging between the active (off-copper) 
conformation, where the O5 atom points towards a conserved active 
site base (Asp), and the inactive (on-copper) conformation, where 
the O5 is in direct contact with copper (Dawkes, 2001) (Figure 4C).  
The two half-reactions of the CAO catalytic reaction follow a 
classical ping-pong mechanism (Figure 4B). In the reductive half-
reaction, the amine substrate reacts with O5 atom of the oxidized 
TPQ forming the substrate Schiff base. The catalytic base abstracts 
the Cα-proton from the substrate forming the product Schiff base 
(Mure et al., 2002). The product Schiff base is hydrolysed releasing 
aldehyde and leaving the enzyme reduced (Klema and Wilmot, 
2012). In the oxidative half-reaction, O2 oxidizes the reduced 
enzyme, releasing ammonia and hydrogen peroxide (Mure et al., 
2002).  
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Figure 4. A: TPQ Biogenesis (Klema and Wilmot, 2012). B: Scheme showing the 
reaction mechanism of CAOs. The oxidative half-reaction is shown in dotted box 
and the reductive in solid box. TPQox, oxidized form of TPQ; SSB, substrate Schiff 
base intermediate; PSB, product Schiff base intermediate; TPQred, reduced form of 
TPQ; TPQsq, semiquinone form of TPQ; TPQimq, iminoquinone form of TPQ 
(adapted from (Finney et al., 2014; Mure, 2004)). C: Chemical structure of TPQ 
showing the torsion angles χ1 and χ2 (Dawkes, 2001). 
2.5. The CAO fold  
To date the structures of CAOs from different sources have been 
solved, which include the mammalian sources human and bovine 
(Table 1) and, despite the overall low sequence identity, they all 
adopt the same archetypal fold. The CAO fold is a heart shaped 
homodimer with each monomer having a ~70-80 kDa mass. CAOs 
from eukaryotic sources have additional mass due to glycosylation 
(Klema and Wilmot, 2012). Each monomer is composed of the D2-D4 
domains (Figure 5A). The D2 and D3 domains have a similar α/β 
fold. Based on their high sequence identity in Escherichia coli 
(ECAO), they have presumably arisen via a gene duplication event 
(Parsons et al., 1995). The D4 domain, where the active site is 
located, is the largest and the most conserved domain (Figure 5A). 
The architecture of D4 is somewhat complex as there are two/three 
β-hairpins that protrude from one monomer to the other monomer. 
The active site is formed partially by residues belonging to the other 
monomer (Figure 5B), which has led to the speculation of a possible 
cooperation between the two monomers (Frébort et al., 1996). 
Recently, it was however found that there is no communication 
between the active sites in Arthrobacter globiforis CAO 
(AGAO)(Gaule et al., 2015). Moreover, the hairpin arms have been 
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thought to be important for the maintenance of the dimer but also to 
have a role in regulating substrate specificity (Klema and Wilmot, 
2012; Wilce et al., 1997). The active site is buried in the end of a 
channel and it contains TPQ, a copper ion coordinated by three 
histidines and a conserved catalytic base (Asp) (Figure 5C). 
Depending on the source, the active site channel has different shape 
and properties. For example, in rodent and primate AOC3 the 
channel has different residues and shape (Bligt-Lindén et al., 2012). 
Moreover, due to these residue differences, some inhibitors might 
not bind equally well to rodent enzymes, which is problematic for 
the preclinical testing of these inhibitors (Bligt-Lindén et al., 2013). 
 
Figure 5. A: Top view of the CAO fold. The domains are color-coded in the 
monomer shown as cartoon where the other monomer of the dimer is shown as 
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grey surface. B: Side view of the CAO fold. Arm I from one monomer protruding 
near the active site of the other monomer. The catalytic centres are indicated with 
dashed boxes. C: Conserved catalytic centre in all CAOs with hAOC3 residue 
numbering. The images were prepared using the crystal structure of hAOC3 PDB 
ID 4BTY (Bligt-Lindén et al., 2013). 
Table 1. Summary of the available crystal structures of mammalian CAOs in the  
Protein Data Bank (PDB). 
2.6. N-glycosylations in hAOC1 and hAOC3 
The addition of glycans on a protein can dramatically alter the 
structure of the protein and consequently its function (Imperiali and 
O’Connor, 1999). For example, the carbohydrates covalently linked 
Protein Organism Ligand TPQ  
conformation 
PDB  
ID 
Reference 
AOC1      
 Human  on-copper 3HI7 (McGrath et al., 2009) 
 Human  Berenil on-copper 3HIG (McGrath et al., 2009) 
 Human Pentamidine on-copper 3HII (McGrath et al., 2009) 
 Human  on-copper 3K5T (McGrath et al., 2010) 
 Human Aminoguanidine off-copper 3MPH (McGrath et al., 2010) 
AOC3      
 Human  on-copper 1PU4 (Airenne et al., 2005) 
 Human  on-copper 1US1 (Airenne et al., 2005) 
 Human  off-copper 2C10 (Jakobsson et al., 2005) 
 Human 2-hydrazinopyridine off-copper 2C11 (Jakobsson et al., 2005) 
 Human  off-copper 3ALA (Ernberg et al., 2010) 
 Human  Imidazole  on-copper 2Y73 (Elovaara et al., 2011a) 
 Human Imidazole  off-copper 2Y74 (Elovaara et al., 2011a) 
 Human  Pyridazinone off-copper 4BTX (Bligt-Lindén et al., 2013) 
 Human  Pyridazinone off-copper 4BTY (Bligt-Lindén et al., 2013) 
AOC4      
 Bovine  off-copper 1TU5 (Lunelli et al., 2005) 
 Bovine Clonidine off-copper 2PNC (Holt et al., 2008) 
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to Asn residues, the N-glycans, play a key role in many biological 
processes (Eklund and Freeze, 2005). The N-glycans can have an 
affect on secretion, stability, expression, adhesion, signalling and 
folding of proteins (Bieberich, 2014; Tannous et al., 2015). The 
attachment of N-glycans to Asn residues may occur at the Asn-X-
Ser/Thr consensus sequence (X can be any residue except Pro) on 
the protein (Tannous et al., 2015) (Figure 6).  
In the ER, the Asn is modified with the attachment of pre-formed 
oligosaccharides made of three glucoses, nine mannoses and two N-
acetylglucosamines. The first terminal glucose is trimmed by alpha-
glucosidase I and the second glucose by alpha-glucosidase II (Figure 
6). The two lectin chaperones, calnexin (CNX) and calreticulin 
(CRT), facilitate the folding. The immature proteins are re-
glycosylated by glycosyltransferance (UGT1), which serves as a 
folding sensor (Tannous et al., 2015). The immature proteins re-enter 
the CNX/CRT cycle. The misfolded proteins or proteins recognized 
as aberrant products undergo the ER-associated degradation 
(ERAD) but the correctly folded proteins are exported from the ER 
to the Golgi, where the glycans are further processed (Bieberich, 
2014). 
 
Figure 6. The N-glycan attached to the Asn-X-Ser/Thr motif. The pre-formed 
oligosaccharide is made of three glucoses (dark gray circles), nine mannoses (light 
gray circles) and two N-acetylglucosamines (black squares). The glycan processing 
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enzymes and their actions points are listed in the top right corner of the figure 
(Adapted from Tannous et al. (2015)). 
The human AOC1 and AOC3 are both N-glycosylated and the 
crystal structures show that the N-glycans are distributed on the 
surface of these proteins (Figure 7). hAOC1 has four N-glycosylation 
sites, Asn110, Asn168, Asn538 and Asn745 (McGrath et al., 2009). 
Whereas hAOC3 has six N-glycosylated sites: Asn137, Asn232, 
Asn294, Asn592, Asn618 and Asn666 (Airenne et al., 2005; Maula et 
al., 2005). The composition of the glycan structures of hAOC1 has 
been recently resolved (Gludovacz et al., 2016). hAOC1Asn110 is 
occupied mainly by oligomannosidic glycans,  hAOC1Asn168 by bi- or 
tetra-antennary complex glycans,  hAOC1Asn538 and hAOC1Asn745 by 
bi-antennary complex type glycans (Gludovacz et al., 2016). 
Regarding hAOC3, only the composition of the glycan attached to 
Asn137 is known (Gludovacz et al., 2018). The mutation of the N-
glycosylation sites in hAOC1 had an effect on protein secretion in 
particular hAOC1Asn110, which is occupied by oligomannosidic 
glycans (Gludovacz et al., 2018). In porcine kidney AOC1 the de-
glycosylation had no effect on enzyme activity and protein stability 
(Schwelberger and Bodner, 1999).  Similar to its homologous 
hAOC1Asn110 site, the hAOC3Asn137 site is mainly occupied by 
oligomannosidic glycans (Gludovacz et al., 2018). Mutational studies 
were done to prevent glycosylation in hAOC3, and they showed that 
hAOC3Asn592, hAOC3Asn618 and hAOC3Asn666 regulate the enzymatic 
activity of hAOC3 (Maula et al., 2005). Moreover, is known that 
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to Asn residues, the N-glycans, play a key role in many biological 
processes (Eklund and Freeze, 2005). The N-glycans can have an 
affect on secretion, stability, expression, adhesion, signalling and 
folding of proteins (Bieberich, 2014; Tannous et al., 2015). The 
attachment of N-glycans to Asn residues may occur at the Asn-X-
Ser/Thr consensus sequence (X can be any residue except Pro) on 
the protein (Tannous et al., 2015) (Figure 6).  
In the ER, the Asn is modified with the attachment of pre-formed 
oligosaccharides made of three glucoses, nine mannoses and two N-
acetylglucosamines. The first terminal glucose is trimmed by alpha-
glucosidase I and the second glucose by alpha-glucosidase II (Figure 
6). The two lectin chaperones, calnexin (CNX) and calreticulin 
(CRT), facilitate the folding. The immature proteins are re-
glycosylated by glycosyltransferance (UGT1), which serves as a 
folding sensor (Tannous et al., 2015). The immature proteins re-enter 
the CNX/CRT cycle. The misfolded proteins or proteins recognized 
as aberrant products undergo the ER-associated degradation 
(ERAD) but the correctly folded proteins are exported from the ER 
to the Golgi, where the glycans are further processed (Bieberich, 
2014). 
 
Figure 6. The N-glycan attached to the Asn-X-Ser/Thr motif. The pre-formed 
oligosaccharide is made of three glucoses (dark gray circles), nine mannoses (light 
gray circles) and two N-acetylglucosamines (black squares). The glycan processing 
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enzymes and their actions points are listed in the top right corner of the figure 
(Adapted from Tannous et al. (2015)). 
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Figure 7. N-glycans distribution on hAOC1 and hAOC3. The glycosylated Asn 
(yellow spheres) and are distributed throughout the surfaces. A: side view and B: 
top view of hAOC1 (PDB ID 3HI7) (McGrath et al., 2009). C: side view and D: top 
view of hAOC3 (PDB ID 4BTX) (Bligt-Lindén et al., 2013).  
2.7. Human CAOs as biomarkers and in drug 
development 
2.7.1. AOC1 
AOC1 is implicated in histamine intolerance due to its role in the 
metabolism of ingested histamine (Maintz and Novak, 2007). The 
AOC1 activity increases significantly in pregnancy. The exact role is 
still unclear, but it has been suggested to be a metabolic barrier that 
prevents the entry of histamine from the placenta into the maternal 
or fetal circulation (Maintz et al., 2008). Low AOC1 activity during 
pregnancy it is linked to high risk pregnancies (Maintz et al., 2008). 
The intra-individual variations of AOC1 levels during pregnancy 
suggest that the levels of AOC1 might not have prognostic 
significance if measured during pregnancy (Maintz et al., 2008). Due 
to the high costs of an AOC1 assay, the measurement of the AOC1 
levels is not yet standard procedure during pregnancies. In 2016, an 
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assay that accurately quantifies AOC1 in various fluids was 
developed and this assay might provide a stepping stone to explore 
the use of AOC1 as a biomarker (Boehm et al., 2016). For example, it 
has been suggested that the levels of AOC1 in non-pregnant women 
can be used to indicate women at risk for complicated pregnancies 
(Maintz et al., 2008).  
Low AOC1 activity might also act as a possible indicator for 
intestinal mucosa damage in inflammatory and oncological diseases 
(Schmidt et al., 1990; Raithel et al., 1998). Additionally, AOC1 is an 
off-target of different commonly used drugs, such as the 
antidepressant amitryptyline and the antibiotic clavulanic acid, and 
thus the intake of these drugs should be taken into account in the 
interpretation of histamine intolerance symptoms and AOC1 
concentrations (Maintz and Novak, 2007). In the assay developed by 
Boehm et al. (Boehm et al., 2016) that quantifies hAOC1 in different 
biological fluids, the effect of the off-target inhibition of AOC1 was 
tackled. Since the potent inhibitors diminazene aceturate and 
aminoguanidine do not interfere with the measurements. 
Altogether, AOC1 has the potential to be used as a biomarker. 
2.7.2. AOC3 
hAOC3 is linked with several diseases and it is a promising drug 
target (Boomsma et al., 2003; Dunkel et al., 2011) with the potential 
use against inflammatory conditions but also against tumour 
progression and the metastatic spread of cancer (Jalkanen and Salmi, 
2017; Salmi and Jalkanen, 2011). The role of hAOC3 in inflammatory 
diseases, diabetes and cancer has been extensively studied using 
animal models (reviewed in Jalkanen and Salmi, 2017). AOC3 can be 
inhibited by small molecule inhibitors (Foot et al., 2012; Inoue et al., 
2013b; Jarnicki et al., 2016; O’Rourke et al., 2008; Schilter et al., 2015; 
Yamaki et al., 2017c, 2017b, 2017a) as well as by antibodies (Arndtz 
et al., 2017; Vainio et al., 2005). However, due to the species-specific 
differences in the active site, in vitro testing and testing in animal 
models can become problematic. For example, the pyridazinone 
inhibitors are potent inhibitors of hAOC3 but weak inhibitors of 
mouse AOC3 (Bligt-Lindén et al., 2013).  
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Soluble AOC3 (sAOC3) has the potential clinical use as a biomarker 
(Pannecoeck et al., 2015), despite that it is not as a general 
inflammation marker (Aalto et al., 2012). Elevated levels of sAOC3 
can be used as a marker for cardiovascular calcifications (Aalto et al., 
2012), liver, gastric and colorectal cancers (Kemik et al., 2010; Li et 
al., 2011; Yasuda et al., 2011) and to predict  cancer mortality in 
colorectal cancer in type-2 diabetes patients (Li et al., 2014). Another 
application for AOC3 as biomarker takes advantages of its adhesion 
function (Aalto et al., 2011). AOC3 is stored inside of the cells but 
upon inflammatory stimuli it is transferred to the endothelial cell 
surface where it prevails during inflammation (Salmi and Jalkanen, 
2014). When the hAOC3 leucocyte ligands, Siglec-10 (Kivi et al., 
2009) and Siglec-9 (Aalto et al., 2011), were found the use of AOC3 
as a target for visualising inflammation using PET imaging was 
developed. A Siglec-9 derived peptide that fits in the enzymatic 
groove of hAOC3 (Aalto et al., 2011) was used in a variety studies 
(Aalto et al., 2011; Jaakkola et al., 2000; Jensen et al., 2017; Li et al., 
2013; Virtanen et al., 2015). 
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3. Aims 
This thesis mainly concentrates on the characterization of 
mammalian CAOs but also cyanobacterial PAOs were analysed. The 
specific aims for this thesis were as it follows: 
I. To study the evolutionary relationship of mammalian CAOs 
in order to aid in the correct annotation of new and poorly 
annotated CAOs and to derive rules to classify AOC1-4 and 
to reveal residues that are important for the substrate 
preference  (publication I). 
II. To study the structure and function of the hAOC-1 attached 
N-glycans with a particular emphasis on the conserved N-
glycosylation site with high-mannose glycosylation in 
hAOC1 and hAOC3 (publication II). 
III. To predict and analyse the interactions between hAOC3 and 
the Siglec-9 derived peptide (publication III) to suggest 
improvements of hAOC3-targeted biomarkers. 
IV. To study the substrate preference and catalytic reaction 
mechanism of the Synechocystis sp. PCC 6803 PAO (SynPAO) 
and give structural explanation for the functional 
characteristics using phylogenetic study, homology 
modelling and structural analysis (publication VI). 
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4. Materials and methods  
4.1. Protein sequence and structure databases 
All the amino acid sequences and protein structures used in this 
thesis were collected from web-based databases. The amino acid 
sequences were collected from UniProtKB (“UniProt: the universal 
protein knowledgebase,” 2017) and from the NCBI Protein database 
(https://www.ncbi.nlm.nih.gov), whereas the protein structures 
were retrieved from the PDB (www.rcsb.org) (Berman et al., 2000). 
Sequence searches were done using the Basic Local Alignment 
Search Tool (BLAST) (Altschul et al., 1990) at NCBI, against non-
redundant protein sequences database.  The BLAST search finds 
regions of local similarity between sequences and calculates the 
statistical significance of the match. 
4.2. Sequence alignments 
All the alignments in this thesis were made in the BODIL modelling 
environment (Lehtonen et al., 2004). In publications I and IV, 
VERTAA (Johnson and Lehtonen, 2000) was used to generate a 
structure-based sequence alignment, which worked as a starting 
point for the multiple sequence alignments. The usage of a pre-
aligned structure-based sequence alignment increases the reliability 
of the residue-residue correspondence and the correct positioning of 
gaps in the final multiple sequence alignment. The multiple 
sequence alignments were done using MALIGN (publication I, III 
and IV) (Johnson et al., 1996). The pairwise alignment used for the 
homology modelling of porcine AOC1 (publication II), was done 
using MALIGN (Johnson et al., 1996). 
4.3. Sequence and phylogenetic analysis 
The amino acid sequences were submitted to SignalP (publication I 
and III) (Petersen et al., 2011) for signal peptide prediction and to 
TMHMM (publication I) (Sonnhammer et al., 1998) and SOSUI 
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(publication IV) (Hirokawa et al., 1998) for transmembrane helix 
prediction. Skylign (publication I) (Wheeler et al., 2014) was used to 
create the sequence logos representing the profile hidden Markov 
models of each alignment. For the phylogenetic study in publication 
I, sequences were curated manually. Sequences without the catalytic 
aspartate, the tyrosine that is post-transcriptionally modified to 
TPQ, and the tree histidines that coordinate the copper ion were 
removed. This ensured that the sequences analysed are catalytically 
active. Additionally, isoforms with the same active site motif were 
removed as they induce redundancy in the trees. 
Phylogenetic trees were constructed using the Maximum Likelihood 
(ML) (publications I and V) and Neighbour Joining (NJ) (Saitou and 
Nei, 1987) (publication I). Due to the size of the dataset in 
publication I, MEGA-CC (Kumar et al., 2012) was used as it allows 
parallel execution on multiple processors and cores, whereas 
MEGA6 (Tamura et al., 2013) was used in publication V. The NJ 
trees were generated using the Jones-Taylor-Thornton (JTT) 
substitution matrix (Jones et al., 1992). For the ML trees, the best-fit 
evolutionary model was assessed using the Bayesian Information 
Criteria (BIC). To generate the trees in publication I, different 
models were chosen based on the BIC score: 1) Poisson correction 
model (Zuckerkandl and Pauling, 1965) with gamma distribution 
and invariant sites (P+G+I) for the tree containing all CAOs, 2) JTT 
with gamma distribution (JTT+G) for the trees with AOC1 and 
AOC2 proteins and 3) JTT with gamma distributions and invariant 
sites (JTT+G+I) for the tree with AOC3 and AOC4 proteins. For 
publication IV, the Lee and Gascuel (Le and Gascuel, 2008) model 
with discrete gamma distributions and invariant sites (LG+G+I) was 
used. The stability of the topology of the phylogenetic trees was 
evaluated using the Felsenstein’s bootstrap replication method 
(Felsenstein, 1985) with 500 replications (publication I and IV). 
To aid in the classification of CAOs and to complement the 
phylogenetic analysis, multivariate analyses was performed by the 
co-author Prof. Mark S. Johnson (publication I). The distance data 
was calculated using the JTT substitution matrix (Jones et al., 1992) 
and supplied to a program to perform a multivariate analysis (PCA, 
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MS Johnson). The program returns a pseudo-PDB coordinate file 
which was visualized using BODIL (Lehtonen et al., 2004). 
4.4. Modelling 
All homology models used in this thesis were created with 
MODELLER (Sali and Blundell, 1993). In publication I, the hAOC2 
model was generated based on the crystal structure of hAOC3 (PDB 
ID 4BTX) (Bligt-Lindén et al., 2013) and, in publication II, the model 
of porcine AOC1 (pAOC1) was generated based on the crystal 
structure of hAOC1 (PDB ID 3HI7) (McGrath et al., 2009). Of the 10 
generated models for each protein, the model with the lowest 
MODELLER objective function was chosen for further analysis 
(publication I and II). Visual inspection of the homology models was 
done by superimposing the model and respective template using 
VERTAA in BODIL (Johnson and Lehtonen, 2000) (publication I and 
II). The models were evaluated using PROCHECK (publication I and 
II) (Laskowski et al., 1993), QMEAN (publication I) (Benkert et al., 
2009), Verify3D (publication II) (Wallner and Elofsson, 2003) and 
ProSA-web (publication II) (Wiederstein and Sippl, 2007).  
The model of hAOC2 (publication I) has 90% of residues in the 
favoured regions of the Ramachandran plot, QMEAN score of 0.704 
(acceptable values range 0-1, the higher value the better), the model 
and template have a root mean square deviation (RMSD) of 0.67 Å 
for the C-alpha atoms of the superimposed structures and share a 
sequence identity of 68%. For the model of pAOC1 (publication II), 
90.7% of residues are in the most favoured region of the 
Ramachandran plot. Based on the Verify3D analysis 85.1% of the 
residues have an average 3D to 1D score of 0.2 or more (threshold to 
pass the test is at least 80% or amino acids with score of 0.2 or more) 
and ProSA-web gave a Z-score of 9.88, which in the range of scores 
typically found for native proteins of similar size. Thus, the models 
were considered reliable for the 3D structural analysis of hAOC2 
and pAOC1. 
The solvent accessibility of the N-glycosylated Asn residues was 
determined by using NACCESS (publication II) 
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(http://bioinf.manchester.ac.uk/naccess/) using a probe size of 5 Å 
to simulate the accessibility of the glycosylating enzymes into the 
glycosylation sites.  
4.5. Ligand docking 
In publication III, the Siglec-9 peptide used as ligand was generated 
using BIOVIA Discovery Studio v4.5 (San Diego, CA, 
www.accelrys.com). The collaborators, Dr. Jerôme de Ruyck and Prof. 
Gerard Vergoten from the University of Lille did the molecular 
docking simulation and the post-docking energy minimization (see 
publication III materials and methods). The best ranking 20 poses 
were evaluated by us. We analysed the docking poses based on 
previously published work on Siglec-9 peptide (Aalto et al., 2011), 
extracellular part of Siglec-9 (Elovaara et al., 2016) and comparison 
with hAOC3 crystal structures (PDB IDs 2Y73, 2Y74 and 4BTY) 
(Bligt-Lindén et al., 2013; Elovaara et al., 2011b). This limits the 
possible poses to those where R3 and R9 interact with the active site 
cavity, R3 binds near TPQ and the terminal Lys is located near the 
protein surface. The interactions were predicted using the PLIP 
server (Salentin et al., 2015) and Maestro (Schrödinger, LLC).  
In publication IV, the spermine structure was downloaded from the 
PubChem database (Kim et al., 2016) and prepared using the 
LigPrep module in Maestro with default settings (LigPrep, version 
3.8; Schrödinger, LLC). The spermine molecule was removed from 
the homology model of SynPAO and the model was prepared 
according to the protein preparation protocol in Maestro  (Maestro, 
version 10-6; Schrödinger, LLC). A docking grid with a positional 
constraint (4.0 Å to the hydroxyl group of Tyr403) was generated to 
cover the active site volume. The docking of spermine to the active 
site of SynPAO was done using Glide (Friesner et al., 2004), ten 
docking poses were generated and ranked based on Emodel score. 
All poses were visually analysed and compared with the spermine 
complex crystal structures of ZmPAO (PDB ID 3KU9; (Fiorillo et al., 
2011)) and yeast Fms1 (PDB ID 1XPQ; (Huang et al., 2005)), and they 
were also compared with the homology model of mouse SMO with 
docked spermine (Tavladoraki et al., 2011). 
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2009), Verify3D (publication II) (Wallner and Elofsson, 2003) and 
ProSA-web (publication II) (Wiederstein and Sippl, 2007).  
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pass the test is at least 80% or amino acids with score of 0.2 or more) 
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typically found for native proteins of similar size. Thus, the models 
were considered reliable for the 3D structural analysis of hAOC2 
and pAOC1. 
The solvent accessibility of the N-glycosylated Asn residues was 
determined by using NACCESS (publication II) 
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(http://bioinf.manchester.ac.uk/naccess/) using a probe size of 5 Å 
to simulate the accessibility of the glycosylating enzymes into the 
glycosylation sites.  
4.5. Ligand docking 
In publication III, the Siglec-9 peptide used as ligand was generated 
using BIOVIA Discovery Studio v4.5 (San Diego, CA, 
www.accelrys.com). The collaborators, Dr. Jerôme de Ruyck and Prof. 
Gerard Vergoten from the University of Lille did the molecular 
docking simulation and the post-docking energy minimization (see 
publication III materials and methods). The best ranking 20 poses 
were evaluated by us. We analysed the docking poses based on 
previously published work on Siglec-9 peptide (Aalto et al., 2011), 
extracellular part of Siglec-9 (Elovaara et al., 2016) and comparison 
with hAOC3 crystal structures (PDB IDs 2Y73, 2Y74 and 4BTY) 
(Bligt-Lindén et al., 2013; Elovaara et al., 2011b). This limits the 
possible poses to those where R3 and R9 interact with the active site 
cavity, R3 binds near TPQ and the terminal Lys is located near the 
protein surface. The interactions were predicted using the PLIP 
server (Salentin et al., 2015) and Maestro (Schrödinger, LLC).  
In publication IV, the spermine structure was downloaded from the 
PubChem database (Kim et al., 2016) and prepared using the 
LigPrep module in Maestro with default settings (LigPrep, version 
3.8; Schrödinger, LLC). The spermine molecule was removed from 
the homology model of SynPAO and the model was prepared 
according to the protein preparation protocol in Maestro  (Maestro, 
version 10-6; Schrödinger, LLC). A docking grid with a positional 
constraint (4.0 Å to the hydroxyl group of Tyr403) was generated to 
cover the active site volume. The docking of spermine to the active 
site of SynPAO was done using Glide (Friesner et al., 2004), ten 
docking poses were generated and ranked based on Emodel score. 
All poses were visually analysed and compared with the spermine 
complex crystal structures of ZmPAO (PDB ID 3KU9; (Fiorillo et al., 
2011)) and yeast Fms1 (PDB ID 1XPQ; (Huang et al., 2005)), and they 
were also compared with the homology model of mouse SMO with 
docked spermine (Tavladoraki et al., 2011). 
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4.6. Visualization 
PyMOL (DeLano, 2002) was used for visualizing the 3D structures 
and models (publication I, II, III and IV) and to generate high-
resolution figures. The labels were added with GNU Image 
Manipulation Program (version 2.8).  
4.7. Experimental work 
My co-authors performed the experimental work for the 
publications included in this thesis. The experiments are explained 
in detail in the Materials and Methods section of the original 
publication (publication II, III and IV).  
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5. Results and discussion 
5.1. Mammalian copper amine oxidases  
The role of human CAOs in various diseases, their 3D structure and 
substrate preferences has been extensively researched (Finney et al., 
2014), in particular, hAOC1 and hAOC3. Despite the known 
differences in the substrate preferences, CAOs are currently divided 
into two sub-families E.C. 1.4.3.21 (primary amine oxidases) and 
E.C. 1.4.3.22 (diamine oxidase). Membrane bound CAOs with 
activity towards monoamines are commonly referred to as 
semicarbazide sensitive amine oxidases (SSAO), which is a poor 
convention as all CAOs are inhibited by semicarbazide (Elmore et 
al., 2002). The soluble plasma CAOs with activity towards 
monoamines are also referred to as soluble amine oxidase 
(SAO)/benzylamine oxidases (BAO). This thesis aims to address the 
ambiguities in the current naming system by creating a more specific 
classification system for CAOs. Additionally, it aims to understand 
which residues in the active site contribute to the substrate 
preference of each CAO subfamily. 
5.2. Evolution of vertebrate CAOs   
The first extensive phylogenetic analysis of vertebrate CAOs was 
made in publication I. The dataset consists of 369 vertebrate CAOs 
sequences (publication I) with the sequence identity ranging 
between ~30% and 99%. To infer the trees two methods were used: 
ML and NJ. As both trees were congruent, the ML tree was used for 
further analysis (Figure 8A). The phylogenetic tree shows that 
vertebrate CAOs are divided into two major branches: (1) AOC1 
proteins and (2) AOC2-4 proteins. The tree shows that AOC2 and 
AOC3/4 proteins are more closely related to each other than to 
AOC1 (Figure 8A).  
AOC1 proteins were found in all bony vertebrates. Based on the 
phylogenetic tree, all AOC1s share the same clade, supported with 
bootstrap 100% (Figure 8A). This suggests a similar substrate 
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preference for the fish, amphibian, reptile, bird and mammalian 
AOC1 protein. Almeida and Beaven (1981) reported that AOC1 has 
activity towards histamine in the brain of lower vertebrates, which 
supports the tree. AOC2-4 proteins were found in Amphibians and 
Amniotes, whereas AOC4 was found only in placental mammals. 
Unlike AOC1, the AOC2 and AOC3 proteins were distributed in 
different clades (Figure 8A). The mammalian and non-mammalian 
proteins were in different sub-clades, supported with bootstrap 85% 
and 99% for the non-mammalian and mammalian proteins, 
respectively (Figure 8A).  
CAOs from Rhincodon typus (whale shark) and Callorhinchus milii 
(elephant shark), which are cartilaginous fishes, were used as out-
group for the phylogenetic analysis (publication I). C. milii has 
diverged ~450 million years ago and it is the slowest evolving 
genome of all known vertebrates, making it a good model to study 
the ancestral state of genomes (Venkatesh et al., 2014). C. milii CAO 
is annotated as “retina-specific amine oxidase” and this protein has 
the highest sequence identity with hAOC2 (~44%), followed by 
hAOC3 (~43%) and hAOC1 (~41%). Similarly, the sequence identity 
of R. typus is also the highest with hAOC2 (~43%) followed by 
hAOC3 (~42%) and hAOC1 (~39%).  
The previous phylogenetic studies published on CAOs either used a 
small number of sequences (ten CAO sequences) (Lai et al., 2012) or 
were focused on the porcine genome (Schwelberger, 2010, 2006). 
Thus results of these studies are very limited. The results from 
publication I, provide a more in-depth knowledge of the 
phylogenetic relationships between mammalian and non-
mammalian CAOs. Since a larger number of CAO sequences from a 
variety of vertebrate species were used in this study.  
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Figure 8. A: ML phylogenetic tree of vertebrate CAOs. B: ML tree topology with the 
corresponding HMM motif logos (Figure from publication I). 
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 5.3. Motif-based classification of mammalian CAOs   
The first structural studies involving CAOs were made using non-
mammalian sources. In the studied species residue X2 of the active 
site motif (X1-X2-Asn-Tyr-Asp) is always a small hydrophobic 
residue: Gly in ECAO, Hansenula polymorpha CAO, AGAO and Pichia 
pastoris CAO, and Ala in Pisum sativum CAO. The structural work 
with hAOC3 showed that X2 is a Leu, which acts as a “guardian” 
residue (Airenne et al., 2005; Salminen et al., 1998). In fact, in the 
mammalian proteins, residue X2 seems to be variable in the different 
CAOs, and it seems to follow the different substrate preference of 
mammalian CAOs: a Tyr in AOC1, a Gly in AOC2, and a Leu in 
AOC3 (Airenne et al., 2005; Kaitaniemi et al., 2009; Salminen et al., 
1998). Altogether, this motivated to study if the residues X1 and X2 
could be used to distinguish between the mammalian CAOs 
(publication I). Since the phylogenetic tree shows that the 
conservations of the motif in vertebrates is in accordance with the 
substrate preference (Figure 8A), residues X1 and X2 were analysed 
with more detail, with special emphasis on mammalian CAOs.  
The active site motif was analysed using the HMM motif logos, and 
related to the tree topology (Figure 8B). Results show that in 
mammals X2 is always a Tyr in AOC1, a Gly in AOC2 and a Leu in 
AOC3/ACO4. Similarly, in the remaining vertebrates residue X2 is a 
Tyr in AOC1 and the majority of AOC2s have a Gly. In AOC3s, X2 is 
less conserved (Figure 8B). It is always hydrophobic but is more 
frequently Ile than Leu in non-mammalians, and some species have 
a Val. Additionally, a different motif was found in some crocodilian 
CAOs, where X2 is a Ser. These proteins were identified as AOCX 
(Figure 8B) and likely have different substrate preference.  
Mammals are the only species with AOC3 and AOC4 (Figure 8A), 
which both have a Leu in position X2 (Figure 8B). Thus, the 
classification of these proteins was further studied. The multiple 
sequence alignment containing only mammalian CAOs showed that 
the average sequence identity of mammalian AOC1s to AOC2s is 
62% and to AOC3/AOC4 it is 60%, whereas the identity of AOC2 to 
AOC3/AOC4 is 73%. Regarding the AOC3 and AOC4 proteins, the 
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sequence identities range between 84% and 98%, which shows that 
these proteins are highly similar. The multivariate plot with 
mammalian CAOs showed three distinct clusters, one per CAO 
subfamily, which is in accordance with the phylogenetic tree of 
vertebrate CAOs (Figure 9A). Thus, it did not help in the 
classification of AOC3 and AOC4. The residue at position X1 in the 
motif was analysed next. When comparing the sequences of hAOC3 
and bAOC4 with the gene information on the collected AOC3 and 
AOC4 proteins, it was found that proteins with a Leu as X1 mostly 
derive from a different gene than proteins with a Met as X1. 
Therefore, proteins with a Leu as X1 were marked as AOC3 and 
proteins with a Met as AOC4 and a multivariate plot was generated. 
In the resulting plot, proteins with a Leu cluster separately from the 
proteins with a Met (Figure 9B) suggesting that CAOs with a Leu 
should be classified as AOC3 and with a Met as AOC4. 
The generated HMM motif logos for each mammalian CAO 
subfamily show the conservation of motif within the same subfamily 
(Figure 9C). Altogether, results from publication I show that the 
TPQ signature motif can indeed be used for the classification of 
mammalian CAOs. This motif-based classification is consistent with 
the different substrate preferences. The Tyr at position X2 in AOC1 
is consistent with the diamine preference of AOC1s, the Gly at 
position X2 in AOC2 is consistent the substrate preference for 
aromatic monoamines, the Leu at X2 at AOC3/AOC4 with the 
aliphatic monoamine preference, and, furthermore the Leu and Met 
at X1 differentiate between the small aliphatic amines and aliphatic 
polyamine preference in AOC3 and AOC4, respectively. 
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Figure 9. A: multivariate plot of mammalian CAOs showing the different 
subfamilies. B: multivariate plot of mammalian AOC3 and AOC4 proteins, blue 
sphere represent outliers. C: Tree topology based on Figure 8A, with the HMM 
motif logo of mammalian CAO proteins. Bbi – Bison bison bison; Bta- Bos taurus; 
Bbu- Bubalus bubalis; Ssc – Sus scrofa; Ame- Ailuropoda melanoleuca; Clu – Canis lupus 
familiaris (Figure from publication I).  
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5.4. Phylogenetic analysis of CAO subfamilies  
In the light of the motif-based classification, the CAO subfamilies 
could be analysed in more detail. This included a phylogenetic 
analysis for each subfamily. The trees were generated separately for 
the AOC1, AOC2 and AOC3/4 subfamilies. In the generated trees, 
the branches are mostly supported by low bootstrap values (Figure 
10-12). This generally occurs when the time frame is short, as there 
are not enough substitutions supporting each node and, thus, the 
dataset as a whole remains sensitive to random fluctuations in the 
observed mutations and small differences (Soltis and Soltis, 2003). 
All the trees have a different topology, which can be seen in rodent 
CAOs of the AOC1 and AOC2 trees. In AOC1, the rodents are 
divided into the two main branches of the tree (Figure 10). 
Myomorpha (mouse-like rodents) rodents form their own branch, 
whereas rodents from the Hystricomorpha, Sciuromorpha and 
Castorimorpha suborders share the same branch as primates and 
Oryctolagus cuniculus (rabbit). Rattus norvegicus (rat; Myomorpha) 
and Cavia porcellus (guinea pig; Hystricomorpha), which both are 
rodents but in different branches of the tree are affected differently 
by the tricyclic antidepressant amitriptyline (Rajtar and Irman-
Florjanc, 2007). Amitriptyline acts as an inhibitor of R. norvegicus 
AOC1, whereas it increased the activity of C. porcellus AOC1 leading 
to a faster histamine inactivation. Their ligand binding properties 
reflect the branching of the phylogenetic tree for AOC1 proteins 
(Figure 10). On the other hand, all rodents AOC2s group together 
and share the same branch as O. cuniculus (Figure 10), which shares 
the same sub-branch as primates.  
Due to the high average sequence identity between AOC3 and 
AOC4 (81%) and the high conservation of the D4 catalytic domain 
(59-100%), the phylogenetic tree for these proteins was generated 
together (Figure 12). Based on the tree it seems that the divergence 
of AOC3-AOC4 proteins occurred in a species-specific way, likely 
due to different evolutional pressure. For example, AOC3 and AOC4 
from monkeys do not share the same most recent last common 
ancestor, whereas bovine AOC3 and AOC4 share (Figure 12). It has 
been suggested previously that species with the AOC4 gene have 
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high level of serum CAO (Schwelberger, 2006). Among these species 
are Ovis aires (sheep), Bos taurus (cow), O. cuniculus, Capra hircus 
(goat), Canis lupus familiaris (dog) and Sus scrofa (pig) (Boomsma et 
al., 2003; Schwelberger, 2006). In general, this is in accordance with 
the results in publication I. However, only one gene was found in C. 
lupus familiaris and S. scrofa. More details about the outliers in this 
study can be found in publication I. The origin of AOC4 has been 
traced to duplication of the AOC3 gene (Schwelberger, 2010). In 
accordance, no AOC4 with the AOC3 motif (X1=Leu) were found, 
but AOC3s were found with a Met as X1. The AOC4 proteins from 
O. cuniculus and S. scrofa have high activity towards mescaline, a 
hallucinogenic plant-derived amine, suggesting a dietary influence 
on the metabolized substrates (Lyles, 1996). Altogether, results from 
publication I suggest that CAOs with predicted AOC4 activity 
(X1=Met), but deriving from the AOC3 gene should not be named as 
AOC3 but as AOC4-like. Furthermore, it is of high importance to 
analyse the genomic origin of the encoded protein.  
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Figure 10. Phylogenetic tree of mammalian AOC1 proteins with HMM motif logo 
in the upper left corner (Figure from publication I).  
 
 
 36 
high level of serum CAO (Schwelberger, 2006). Among these species 
are Ovis aires (sheep), Bos taurus (cow), O. cuniculus, Capra hircus 
(goat), Canis lupus familiaris (dog) and Sus scrofa (pig) (Boomsma et 
al., 2003; Schwelberger, 2006). In general, this is in accordance with 
the results in publication I. However, only one gene was found in C. 
lupus familiaris and S. scrofa. More details about the outliers in this 
study can be found in publication I. The origin of AOC4 has been 
traced to duplication of the AOC3 gene (Schwelberger, 2010). In 
accordance, no AOC4 with the AOC3 motif (X1=Leu) were found, 
but AOC3s were found with a Met as X1. The AOC4 proteins from 
O. cuniculus and S. scrofa have high activity towards mescaline, a 
hallucinogenic plant-derived amine, suggesting a dietary influence 
on the metabolized substrates (Lyles, 1996). Altogether, results from 
publication I suggest that CAOs with predicted AOC4 activity 
(X1=Met), but deriving from the AOC3 gene should not be named as 
AOC3 but as AOC4-like. Furthermore, it is of high importance to 
analyse the genomic origin of the encoded protein.  
 37 
 
Figure 10. Phylogenetic tree of mammalian AOC1 proteins with HMM motif logo 
in the upper left corner (Figure from publication I).  
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Figure 11. Phylogenetic tree of mammalian AOC2 proteins with HMM motif logo 
in the upper left corner (Figure from publication I).  
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Figure 12. Phylogenetic tree of mammalian AOC3 (orange) and AOC4 (violet) 
proteins with HMM motif logos in the upper left corner (Figure from publication I).  
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Figure 11. Phylogenetic tree of mammalian AOC2 proteins with HMM motif logo 
in the upper left corner (Figure from publication I).  
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Figure 12. Phylogenetic tree of mammalian AOC3 (orange) and AOC4 (violet) 
proteins with HMM motif logos in the upper left corner (Figure from publication I).  
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5.5. Active site of mammalian CAOs  
The area surrounding TPQ was studied in the 3D structures of 
hAOC1 (PDB ID 3MPH; McGrath et al., 2009), hAOC3 (PDB ID 
4BTX; Bligt-Lindén et al., 2013) and bAOC4 (PDB ID 1TU5; Lunelli et 
al., 2005), and in the homology model of hAOC2. Half of the 
residues near TPQ are fully conserved (Figure 13), and most of them 
are involved in TPQ biogenesis and/or catalytic mechanism 
(Airenne et al., 2005; Ernberg et al., 2010; Klema and Wilmot, 2012). 
The catalytic Asp (Aps373 in hAOC1) and a nearby Tyr (Tyr371 in 
hAOC1) make the conserved Y-X-D motif. The Tyr in this motif has 
been identified as a “gate” residue in mammalian CAOs (Kaitaniemi 
et al., 2009; Salminen et al., 1998). This Tyr likely interacts with the 
amine substrates of mammalian CAOs similarly, as it interacts with 
the pyridine ring in the crystal structure of hAOC3 with 2HP 
(Jakobsson et al., 2005) and it possibly interacts with the aromatic 
ring of benzylamine in hAOC3 (Kaitaniemi et al., 2009). TPQ is 
oriented by two conserved Tyr (Tyr359 and Tyr463 in hAOC1) and a 
Asn (Asn460 in hAOC1) (Airenne et al., 2005; Ernberg et al., 2010), 
whereas the conserved Ser in the vicinity of TPQ (Ser465 in hAOC1) 
forms hydrogen bonds that stabilize the active site architecture 
(Figure 13A). The conserved hydroxyl containing residue (Ser/Thr; 
Thr457 in hAOC1) and the Asp from the motif (Asp462 in hAOC1) 
form an hydrogen bond. This interaction is part of an inter-
monomeric hydrogen bond network that together with fully 
conserved Arg (Arg492 in hAOC1) and His (His430 in hAOC1) from 
the other monomer stabilizes the tip of the β-hairpin. Similar 
hydrogen bonding network has been identified also in ECAO 
(Parsons et al., 1995). 
The non-conserved residues in the area surrounding TPQ are likely 
responsible for the different substrate preference of CAOs (Figure 
13). The diamine preference is unique to hAOC1 (Elmore et al., 
2002), and based on the phylogenetic tree (Figure 8), the AOC1 
subfamily shares the substrate preference. AOC1 proteins have a set 
of uniquely conserved residues that seem to contribute to the 
diamine preference (Val458, Tyr459 and Asp186 in hAOC1). Tyr459 
in hAOC1 together with a conserved aromatic residue (Trp367 in 
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hAOC1) are in a suitable position to orient the substrates, whereas 
Asp186 is suitable for binding the second diamine group. This is in 
accordance with a study made by McGrath and co-workers (2009), 
which predicted Asp186 to be involved in histamine binding. Val458 
is also conserved in AOC2s, which suggests that it contributes to the 
aromatic substrate preference. The extra space in the active site of 
AOC2, due to the small residues Gly (X2) and Val (X1) (Gly463 and 
Val462 in hAOC2) from the active site motif, provides an optimal 
environment for the aromatic ring of the substrates. In fact, Gly has 
been shown to be important for p-tyramine binding, since after the 
mutation of Leu in hAOC3 to a Gly, hAOC3 acquired activity 
towards p-tyramine, which the hAOC3 wild type did not have 
(Elovaara et al., 2011). In the same position as Asp186 in hAOC1, 
there is a His in hAOC2 (His206). This residue could interact with 
polar and/or aromatic substrates. The His is conserved in AOC2s, 
with the exception of bats that have a Gln. Thus, it can be postulated 
that His is specific to AOC2 and contributes to its substrate 
preference.  
AOC3 prefers small aliphatic amines, whereas AOC4 long 
polyamines (Bonaiuto et al., 2010; Elovaara et al., 2011; Kaitaniemi et 
al., 2009). In both proteins, X2 is a Leu, which has been associated 
with blocking/allowing access to TPQ (Airenne et al., 2005; 
Jakobsson et al., 2005; Kaitaniemi et al., 2009; McGrath et al., 2009). 
Mutational studies of this residue have shown that it is involved in 
the substrate preference of hAOC3 (Elovaara et al., 2011; Kaitaniemi 
et al., 2009). This Leu together with a conserved Phe in AOC3 and 
AOC4 (Phe389 in hAOC3), provide a hydrophobic environment in 
the active site that can accommodate the carbon tails of aliphatic 
amines (Figure 13C and D). The residue X1 is a Leu in AOC3 and a 
Met in AOC4. The exact role of this residue is not yet known, but the 
difference provides the active site of AOC4 a slightly more polar 
nature, when compared to AOC3 (Figure 10). In the same position as 
Asp186 in hAOC1, there is a conserved Thr in AOC3 (Thr212 in 
hAOC3), and an almost conserved Asn in AOC4 (Asn211 in bAOC4) 
(Figure 13C and D). Moreover, in hAOC3, it has been shown by 
mutational studies that Thr212 merely has a role as an additional 
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gate, contributing only slightly to substrate preference (Elovaara et 
al., 2011).  
Rodents have been used as model organism in human AOC3 related 
research, for diseases, drug design and in vivo imaging, whereas 
AOC4 related research has been focusing on bAOC3. The studies on 
the substrate preference of CAOs have been mainly done using 
human and rodent proteins (Elmore et al., 2002; Finney et al., 2014; 
Lyles, 1996; Shen et al., 2012; Zhang et al., 2003). The species-specific 
differences that have been noticed in the drug design projects are 
known the be problematic (Bligt-Lindén et al., 2013; Foot et al., 2012; 
Inoue et al., 2013a, 2013b). The comparison of rodent and primate 
proteins suggests that for small substrates and inhibitors binding 
covalently to TPQ, rodents and other primates might serve as a good 
model for humans, as the active site in that region is quite 
conserved. However, for larger inhibitors, the active site channel of 
the model organism should be studied in detail. Moreover, besides 
the species-specific properties of the active site, it is crucial to take 
into account the other CAO proteins expressed in the model 
organism.  
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Figure 13. Active site of the different mammalian CAOs. A: hAOC1; B: hAOC2; C: 
hAOC3; D: bAOC4. (Figure from publication I). 
5.6. The conserved N-glycosylation site in CAOs  
A N-glycosylation site is among the conserved characteristics of 
mammalian CAOs. The site is located in the β1.3 β-strand that 
precedes the loop linking the two β-strands in the central four-
stranded β-sheet of the D2 domain. This glycosylation site, which is 
hAOC1Asn110, pAOC1Asn115 and hAOC3Asn137, is predominantly 
occupied by oligomannosidic glycans. Among AOC1 proteins, this 
N-glycosylation site has the highest degree of conservation 
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(publication II). Additionally, it is also the most conserved N-
glycosylation site among the CAO proteins of the dataset in 
publication I. Altogether, the data suggests that this glycosylation 
site is conserved for about 450 million years (Venkatesh et al., 2014).  
The mutation of Asn110 to a Gln in hAOC1, which prevents the N-
glycosylation of the site, showed that the mutant activity was at least 
100-fold lower than the wild type. The results showed that the 
oligomannose glycan attached to Asn110 is essential for hAOC1 
folding and secretion. Based on the analysis of recombinant AOC1s, 
and hAOC3 from different sources this conserved N-glycosylation 
site consistently has oligomannosidic glycans (publication II).  To 
analyse the relationship between the 3D structural features and the 
uncommon oligomannosidic glycosylation, the crystal structures of 
hAOC1 and hAOC3 as well as the homology model of pAOC1 were 
analysed in publication II. The overall sequence identity between 
hAOC1 and hAOC3 is 38%, while the sequence identity in the area 
surrounding the conserved N-glycosylation site its 67% (sequence 
similarity is 80%) (Figure 14A). In both proteins, the site is located in 
a cleft surrounded by hydrophobic residues in one side (Figure 14B-
E). It also seems that this site is poorly accessible for the glycan 
processing enzymes that process high-mannose glycans to complex 
glycans, as the rate of final cis-Golgi mannose trimming to Man5 
was decreased. Man5 is crucial for the addition of GlcNAc by the N-
acetyl-glucosamiyltransferase-1 (GnT1), followed by the trimming to 
Man3 by alpha-mannosidae II. Thus the conversion to complex 
glycans seems to be limited. This is supported by the unsuccessful 
attempts to release the glycan at this site by N-glycosidase F, as the 
core region is not accessible (publication II).  
Based on the structural analysis, the attached N-glycans are 
stabilized by conserved hydrogen bonds between the amide oxygen 
of the glycosylated Asn and the hydroxyl group of Thr or Ser in the 
N-glycosylation motif of hAOC1 or hAOC3, respectively. 
Furthermore, the conserved Gln residues form hydrogen bonds with 
the first GlcNAc of the glycan in each protein (Figure 14F-G). The N-
acetyl methyl group of the second GlcNAc in the core trisaccharide 
forms hydrophobic interactions with two Phe residues that are part 
of the hydrophobic core of the D2 domain (Figure 15A). hAOC1 and 
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pAOC1 share a sequence identity of 85% and the three conserved 
glycosylation sites, including  hAOC1Asn110. In the model of porcine, 
this site is also located in a hydrophobic core with a similar 
accessibility than hAOC1Asn110 (publication II). Furthermore, the 
conserved hAOC1Asn110 N-glycosylation site seems to be essential for 
the secretion and for to the correct folding of both hAOC1 and likely 
also for CAOs deriving from different sources.  
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Figure 14. The conserved N-glycosylation site in hAOC1 and hAOC3. A: Sequence 
alignments with residues surrounding the Asn-Val-Ser/Thr motif. The identical 
residues are shown in bold, and the residues that preserve the hydrophobic nature 
marked with +. B: Close-up view of hAOC1Asn110. C: Close-up view of hAOC3Asn137. 
D: Surface view of hAOC1Asn110. E: Surface view of hAOC3Asn137.  Conserved residues 
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and residues with a conserved hydrophobic nature shown as white sticks. The 
hydrophobic regions on the surface are in cyan. F: Interactions between the glycan 
and hAOC1 in the region surrounding hAOC1Asn110. G: Interactions between the 
glycan and hAOC3 in the region surrounding hAOC3Asn137 (Figure from publication 
II). 
5.7. Structural characterization of the N-glycosylation 
sites in AOC1  
The mutation of the remaining N-glycosylation sites, Asn538, 
Asn745 and Asn168, had an effect on hAOC1 secretion and reduced 
secretion by 71%, 32% and 13%, respectively (publication II). Thus, 
the structure of the surrounding regions in the remaining N-
glycosylation sites of hAOC1 was also analysed in publication II to 
infer the possible structural role of these N-glycosylations. Asn168 is 
conserved only in primates and the composition of the glycans in 
this site varies between samples. This site has predominantly 
complex type glycans with high antennary and 100% fucosylation. 
Asn168 is located on a flat surface in the 3D structure of hAOC1 
(Figure 15B). Consistently with the complex type of Asn168-attached 
glycans, Asn168 is readily accessible for the glycan-processing 
enzymes (publication II).  
Asn538 and Asn745 are both occupied by similar complex-type 
glycans with similar antennary. They are both located in the D4 
domain of hAOC1 and conserved in pAOC1. Asn538 is located next 
to the tip of Arm 1 of the β-hairpin (β4.3 β-strand), which extend 
from one monomer to the other. The region formed by the residues 
+3 to +7 from Asn538 is part of the tip of Arm 1 (Figure 15C). This 
evolutionary conserved region plays an important role in attaching 
Arm 1 into the D3 domain of the other monomer and the $-stacking 
interaction between Trp643 and Trp200 of the D3 domain seems to 
be particularly important. The inter-monomeric interactions are 
further stabilized by the hydrophobic interactions between the first 
N-acetyl methyl of the GlcNac with Pro606 and Trp609 from the D4 
domain of the other monomer.  Asn745 is located on the active site 
entrance near the C-terminus in the D4 domain. It is part of an 
extensive hydrogen-bonding network that connects the C-terminus 
to the core of D4 and to the Arm 2 from the other monomer (Figure 
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to the core of D4 and to the Arm 2 from the other monomer (Figure 
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15D). The first GlcNAc of the glycan makes a water mediated 
hydrogen bond to Asn724 of the Arm 2 from the other monomer. 
Altogether, the location of the N-glycosylated sites on the 3D 
structure and the formed protein-glycan interactions explain the 
effect of the mutations on hAOC1 secretion and activity. In 
particular, the N-glycan attached to the site in the vicinity of the 
inter-domain Arms are important for the structural integrity, which 
is in accordance with the Arms being important for the maintenance 
of the dimer stability (Klema and Wilmot, 2012). pAOC1 has two 
glycosylation sites, which are not conserved with hAOC1, 
pAOC1Asn437 and pAOC1Asn749. They form a cluster of glycans near the 
active site entrance together with pAOC1Asn794 (hAOC1Asn745) 
(publication II). This cluster of glycans might facilitate local folding 
and dimerization efficiency.  
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Figure 15. Close-up viewed of the N-glycosylation sites in AOC1 showing the 
surrounding residues and interactions. A: hAOC1Asn110, B: hAOC1Asn168*, C: 
hAOC1Asn538 D: hAOC1Asn745. *not glycosylated in the published structures of hAOC1 
(Figure from publication II). 
 5.8. Interactions between the Siglec-9 peptide and the 
N-glycosylated hAOC3  
hAOC3 is a target for drug discovery and development and it also 
has a potential to be used as a biomarker for inflammation (Autio et 
al., 2013). The hAOC3-Siglec-9 interaction provides a powerful tool 
for in vivo imaging of leucocyte trafficking at sites of inflammation 
(Figure 16). In 2011, Aalto et al. found that Siglec-9 binds to the 
enzymatic grove of AOC3 and docking studies confirmed that the 
peptide indeed could fit into the active site cavity of AOC3 (Aalto et 
al., 2011). It was proposed that one of the arginines in the peptide 
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N-glycosylated hAOC3  
hAOC3 is a target for drug discovery and development and it also 
has a potential to be used as a biomarker for inflammation (Autio et 
al., 2013). The hAOC3-Siglec-9 interaction provides a powerful tool 
for in vivo imaging of leucocyte trafficking at sites of inflammation 
(Figure 16). In 2011, Aalto et al. found that Siglec-9 binds to the 
enzymatic grove of AOC3 and docking studies confirmed that the 
peptide indeed could fit into the active site cavity of AOC3 (Aalto et 
al., 2011). It was proposed that one of the arginines in the peptide 
 50 
would bind covalently to TPQ but the later work with the 
extracellular part of Siglec-9 challenged the assumption (Elovaara et 
al., 2016). Although the in vivo imaging concept has been verified in 
various preclinical tests (Aalto et al., 2011; Jaakkola et al., 2000; 
Jensen et al., 2017; Li et al., 2013; Virtanen et al., 2015), details on the 
molecular level of the interaction still remain to be discovered. In 
publication III, the binding mode of the Siglec-9 peptide to hAOC3 
was re-evaluated in light of the new data. Additionally, the N-
glycans attached to hAOC3 (publication III) were for the first time 
taken into account as the N-glycans of hAOC3 were known to be 
involved in lymphocyte adhesion and in regulating the enzymatic 
activity (Maula et al., 2005).  
 
Figure 16. hAOC3 is stored inside the endothelial cells, where upon inflammatory 
stimuli it is released to the cell surface. A radiolabel peptide derived from the 
leucocyte ligand of hAOC3, Siglec-9, can be used for in vivo PET imaging of 
inflammation.  
The docking results shows that the Siglec-9 peptide makes extensive 
intermolecular interactions with hAOC3 (Table 2) and effectively 
occupies its active site cavity (Figure 17A). R3 from the peptide 
protrudes in the active site forming hydrogen bonds with Tyr372 
and Asn470, a salt bridge with Asp386 and hydrophobic interactions 
with Tyr384 (Figure 17B). R9 interacts in a pocked formed by 
hAOC3 and the glycan attached to Asn232. It forms hydrogen bonds 
to the first GlcNAc unit of Asn232 and interacts with Val209, Phe238 
and Tyr488 from hAOC3 (Figure 17C). The other peptide-hAOC3 
interactions of are listed in Table 3. The docking results are in 
accordance with Aalto et al. 2011, where R3 protrudes in the active 
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site. However, R3 does not directly bind to TPQ since based on the 
docking the binding of R3 in the catalytic site seems to occur when 
TPQ is in on-copper conformation. The fact that the peptide seems to 
bind to the on-copper TPQ conformation is in agreement with the 
earlier results that Siglec-9 is not a substrate for hAOC3 (Elovaara et 
al., 2016) as substrates bind to CAOs when TPQ is on the off-copper 
conformation (Klema and Wilmot, 2012) .   
Next, the effect of the hAOC3 inhibitors, semicarbazide and 
imidazole, in the Siglec-9 peptide-hAOC3 interaction were studied 
(publication III). The predicted binding mode of the peptide was 
compared with docked semicarbazide and with the hAOC3 crystal 
structures in complex with imidazole (Figure 17D-F). Semicarbazide 
is an irreversible inhibitor of hAOC3, while imidazole reversibly 
inhibits hAOC3. Both inhibitors bind to TPQ but imidazole has an 
additional binding site in the active site channel (Figure 17D-E). The 
binding of the Siglec-9 peptide was not significantly affected when 
semicarbazide was injected before the peptide, suggesting that R3 
can bind in a different binding site when the access to TPQ is 
blocked by semicarbazide. This site is likely the second binding site 
for imidazole (Figure 17E). This suggests that R3 interacts with TPQ 
like semicarbazide when TPQ is accessible but when the access to 
the active site is blocked by the bound semicarbazide, R3 may 
interact with Tyr394 and Thr212 like imidazole. 
Similarly to the extracellular domain of Siglec-9 that increased the 
hAOC3 activity (Elovaara et al., 2016), the Siglec-9 peptide increased 
the activity of hAOC3 towards benzylamine by 1.3 fold (publication 
III). Since peptides with R3A, R9A and R3A/R9A mutations also 
increased the activity by approximately 1.4, 1.3 and 1.6 fold, 
respectively (publication III) the arginine residues in the peptide 
cannot be crucial for modulating hAOC3 activity. Results suggest 
that the Siglec-9 peptide would enhance the catalytic activity of 
hAOC3 by binding to TPQ when it is in the off-copper conformation 
but without blocking the access to TPQ (publication III). This could 
be the consequence of a conformational change in hAOC3, which 
allows a better access to TPQ. In a study made with lentil CAO it 
was showed that the both the D2 and D3 domains can move 
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is an irreversible inhibitor of hAOC3, while imidazole reversibly 
inhibits hAOC3. Both inhibitors bind to TPQ but imidazole has an 
additional binding site in the active site channel (Figure 17D-E). The 
binding of the Siglec-9 peptide was not significantly affected when 
semicarbazide was injected before the peptide, suggesting that R3 
can bind in a different binding site when the access to TPQ is 
blocked by semicarbazide. This site is likely the second binding site 
for imidazole (Figure 17E). This suggests that R3 interacts with TPQ 
like semicarbazide when TPQ is accessible but when the access to 
the active site is blocked by the bound semicarbazide, R3 may 
interact with Tyr394 and Thr212 like imidazole. 
Similarly to the extracellular domain of Siglec-9 that increased the 
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allows a better access to TPQ. In a study made with lentil CAO it 
was showed that the both the D2 and D3 domains can move 
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(Dainese et al., 2014). Similar domain movement could occur in 
hAOC3. Furthermore, the results obtained with the Siglec-9 peptide 
are similar with the results obtained with the extracellular region of 
Siglec-9, suggesting a similar binding mode and further 
demonstrating that peptides are a good model to study protein-
protein interactions.  
 
 
Figure 17. A: Side view of the docked peptide in the active site of hAOC3. B: Close-
up view of R3 in the docked peptide. C:  Close-up view of R9 in the docked 
peptide. D: Close-up view of docked semicarbazide (SC) with red dotted box 
showing the semicarbazide binding site. E: Close-up view of the imidazole binding 
sites Imi1 (red dotted box) and Imi2 (black dotted box). F: Peptide docked in the 
active site of hAOC3 with the sites Imi1 (red dotted box) and Imi2 (black dotted 
box) highlighted (Figure adapted form publication III). 
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Table 2. Predicted interactions between hAOC3 and the Siglec-9 derived peptide 
(sequence: CARLSLSWRGLTLCPSK). The residues in the active site of different 
organism used for the PET studies are also listed in the table, with conserved 
residues in bold. Residues in grey background are not present in the Siglec-9 C22 
domain. SC = Side chain; MC = Main chain; H-bond = Hydrogen bond. aArm I of 
chain A (Table  from publication III). 
 
5.9. Siglec-9 peptide binding in model organism  
It is currently well known that the ligand binding and detailed 
catalytic properties of CAOs differ between species (Dunkel et al., 
2011), e.g. mouse AOC3 can oxidize a wider range of substrates than 
hAOC3 (Bono et al., 1999). Therefore, results obtained with one 
species cannot be directly applied to other species without a careful 
comparison of the binding site. The preclinical PET studies with the 
Sigelc-9 peptide targeting AOC3 have been made using many model 
organisms (Aalto et al., 2011; Jaakkola et al., 2000; Jensen et al., 2017; 
Li et al., 2013; Virtanen et al., 2015). Thus, in publication III the 
species-specific differences of AOC3 that could influence the binding 
of the Siglec-9 peptide to AOC3 in the model organisms were taken 
into account.  
Siglec-9 peptide is a bulky ligand that interacts in the least 
conserved part of the active site of the AOC3 protein. The overall 
sequence identities of hAOC3 are 82% and 83% to mouse and rat 
AOC3s. The pig and rabbit enzymes share a slightly higher identity 
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to hAOC3 (85% and 84%, respectively). The comparison of the 
residues predicted to be involved in peptide binding show that in 
general these residues are conserved or conservatively replaced 
(Table 2). R3, which binds near TPQ, interacts with the most 
conserved part of the active site channel. All the residues interacting 
with R3 are conserved and, thus, we could expect similar interaction 
in all the above-mentioned species. R9 interacts with the least 
conserved part of the channel. In fact, R9 interacts with two non-
conserved residues, Val209 and Tyr448. Val209 is conserved in 
pAOC3, but replaced by Ala in rabbit and Leu in mouse and rat 
enzymes. Tyr448 is replaced by a His in rabbit and Arg in pig AOC3. 
Moreover, rabbit AOC3 lacks the N-glycosylation site corresponding 
to hAOC3Asn232 and thus it cannot make the glycan-R9 interactions. In 
accordance with the residue differences, the Siglec-9 peptide has 
been reported to bind pig and rabbit AOC3 more weakly compared 
to human AOC3 (Jensen et al., 2017). Altogether, these results 
underline the importance of the acknowledging the species-specific 
differences of AOC3 in model organisms and its consequences for in 
vivo imaging of inflammation using the Siglec-9 peptide.  
5.10. Characterization of SynPAO  
In publication IV, a cyanobacteria PAO (Synechocystis sp. PCC 6803 
PAO; SynPAO) was characterized for the first time. SynPAO has 
substrate preference for spermine and spermidine. It can weakly 
oxidize N1-acetyl spermine but it has no activity towards the 
diamines putrecine and cadaverine. The analysis of the reaction 
products (publication IV) showed that SynPAO is involved in the 
back-conversion pathway (exo-mode oxidation) similar to AtPAO1-5 
(Fincato et al., 2011; Tavladoraki et al., 2016, 2006). 
SynPAO shares sequence identities from ~18% to 50% with the PAO 
sequences studied in publication IV and ~50% sequence identity 
with the cyanobacterial PAOs. The phylogenetic tree shows three 
major branches of PAOs (Figure 18): branch I with animal PAOs, 
AtPAO5 and similar proteins, branch II with cyanobacterial, 
bacterial and plant PAOs (including SynPAO, AtPAO1 and 
ZmPAO), and branch III with AtPAO2, AtPAO3, AtPAO4 and 
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similar proteins. The further analysis was focused on branch II, 
which has SynPAO. This branch is divided into bacterial and plant 
sub-branches, supported with a bootstrap value of 100% (Figure 18). 
The bacterial branch includes SynPAO and other bacterial proteins 
that are not yet characterized. The plant branch is divided into two 
sub-branches. One of them has proteins involved in the terminal 
catabolic pathway (the TC branch) and the other branch has proteins 
involved in the back-conversion pathway (the BC branch) (Figure 
18). The TC branch contains ZmPAO, HvPAO1, HvPAO2 and 
OsPAO7 known to be involved in the terminal catabolic pathway 
(Cervelli et al., 2006; Liu et al., 2014b; Tavladoraki et al., 1998), 
Additionally, the TC branch has the PAO2 proteins that form their 
own sub-branch (bootstrap 100%). These proteins have a C-terminal 
extension with a highly conserved AEAK sequence motif, which is a 
vacuolar sorting signal necessary for the intracellular location 
(Cervelli et al., 2006).  Furthermore, the branching pattern is in 
accordance with the substrate preference of the barley proteins 
HvPAO1 and HvPAO2 (Cervelli et al., 2006). AtPAO1 that is 
involved in the back-conversion pathway and the Nicotina tabacum 
PAO (NtPAO) that has 83% sequence identity to AtPAO1 are in the 
BC branch. Accordingly, it has been suggested that NtPAO and 
AtPAO1 have similar catalytic properties (Tavladoraki et al., 2006). 
A Malus domestica  (MdPAO) also shares the BC branch and it is 
likely involved in the back conversion pathway. The phylogenetic 
tree in Figure 18 has a topology similar with the previously 
published trees of plant PAOs (Ono et al., 2012; Takahashi et al., 
2010; Tavladoraki et al., 2016) and the tree topology is consistent 
with the known oxidation modes of plant PAOs. Furthermore, the 
topology is in accordance with the findings made by Ahou and co-
workers (Ahou et al., 2014), in which AtPAO5 was found to be more 
similar to mouse spermine oxidase (MmSMO) and mouse polyamine 
oxidase (MmPAO) than to AtPAO1-4.  
Spermine was docked into the 3D model of SynPAO to predict the 
binding mode and the results were compared with the spermine 
binding mode of the PAOs having different oxidation modes (Figure 
19). Additionally, sequences from the proteins in branch II (Figure 
18) were compared with the active site of the spermine complex 
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structures of ZmPAO (Fiorillo et al., 2011) (terminal conversion) and 
yeast Fms1 (Huang et al., 2005) (back conversion), the model of 
MmSMO (Tavladoraki et al., 2011), and the 3D model of SynPAO 
(publication IV) with docked spermine (Table 3). The aromatic 
sandwich formed by Phe403 and Tyr439 in ZmPAO (Figure 19A) is 
important for creating the correct substrate conformation for the 
endo-mode reaction (Binda et al., 1999; Fiorillo et al., 2011). This 
aromatic sandwich is also conserved in plant PAOs involved in the 
exo-mode reaction (Table 3, blue) and, thus, it is not the key for the 
endo-mode oxidation. Similar to Fms1 and MmSMO, bacterial PAOs 
lack this aromatic sandwich (Figure 19). Tyr439 in ZmPAO is 
replaced by a non-aromatic residue (Table 3, Thr440 in SynPAO) and 
Phe403 of ZmPAO is replaced by a Tyr in bacterial PAOs, MmSMO, 
and Fms1 (Table 4, Tyr403 in SynPAO). In ZmPAO, Glu62 and 
Glu170 are important in positioning spermine (Binda et al., 2001, 
1999). These residues are totally conserved in all plant PAOs that 
catalyse the endo-mode reaction (Table 3). Glu62 (ZmPAO) is either a 
Ala or Val in plant PAOs catalysing the exo-mode of reaction (Table 
3). These PAOs however have a conserved Glu that could replace 
this residue (N195 Fms1 Table 3). In Fms1, MmSMO and bacterial 
PAOs, Glu62 of ZmPAO corresponds to a His and the corresponding 
residue is Gln94 in SynPAO (Table 3). Glu170 of ZmPAO is 
conserved in all the studied plant and bacterial PAOs (Table 3). 
Mutational studies of Fms1 show that His76 positions the substrate 
for the hydride transfer to flavin (Adachi et al., 2012). Accordingly, 
the mutation H82Q in MmSMO increased the Km about 2-fold 
compared with wild-type enzyme supporting the role of this residue 
in substrate binding (Tavladoraki et al., 2011). Based on docking 
studies in publication IV the corresponding residue in SynPAO, 
Glu62, is predicted to interact with the N1 nitrogen of spermine 
(Figure 19C). Moreover, the docking results are consistent with the 
exo-oxidation mode oxidized by SynPAO. The phylogenetic study 
showing that SynPAO shares the same sub-tree as the other proteins 
known to be involved in the back-conversion pathway are in line 
with the experimental results. Moreover, Gln94, Tyr403, and Thr440 
were identified as the key residues in the active site of SynPAO 
(Figure 19C).  
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Figure 18. ML tree of amine oxidases from different organisms. Branch II contains 
SynPAO (highlighted in cyan) together with other cyanobacteria and bacterial 
proteins within the bacterial subbranch (cyan). In the plant subbranch there are 
some proteins known to catalyze the terminal catabolism (TC), including ZmPAO 
(highlighted in pink), HvPAO1, HvPAO2 and OsPAO7, in the pink subbranch. The 
blue branch of the plant subbranch has plant proteins that catalyze the back-
conversion pathway (BC) e.g. AtPAO1. Yeast Fms1 is highlighted in green. To 
identify the species origin of the proteins, the following species acronyms were 
used: Ai, Arachis ipaensis; At, Arabidopsis thaliana; Bd, Brachypodium distachyon; Bj, 
Branchiostoma japonicum; Bn, Brassica napus; Bo, Brassica oleracea; Br, Brassica rapa; 
Ca, Cyanobacterium aponinum; Cg, Crassostrea gigas; Cs, Camelina sativa; Do, 
Dichanthelium oligosanthes; Fcy, Filamentous cyanobacterium; Fv, Fragaria vesca; Ga, 
Gossypium arboreum; Gm, Glycine max; Gs, Glycine soja; Ha, Halomonas alkaliantartica; 
Hs; Homo sapiens; Hv, Hordeum vulgare; Jc, Jatropha curcas; Ma, Microcystis aeruginosa; 
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Figure 18. ML tree of amine oxidases from different organisms. Branch II contains 
SynPAO (highlighted in cyan) together with other cyanobacteria and bacterial 
proteins within the bacterial subbranch (cyan). In the plant subbranch there are 
some proteins known to catalyze the terminal catabolism (TC), including ZmPAO 
(highlighted in pink), HvPAO1, HvPAO2 and OsPAO7, in the pink subbranch. The 
blue branch of the plant subbranch has plant proteins that catalyze the back-
conversion pathway (BC) e.g. AtPAO1. Yeast Fms1 is highlighted in green. To 
identify the species origin of the proteins, the following species acronyms were 
used: Ai, Arachis ipaensis; At, Arabidopsis thaliana; Bd, Brachypodium distachyon; Bj, 
Branchiostoma japonicum; Bn, Brassica napus; Bo, Brassica oleracea; Br, Brassica rapa; 
Ca, Cyanobacterium aponinum; Cg, Crassostrea gigas; Cs, Camelina sativa; Do, 
Dichanthelium oligosanthes; Fcy, Filamentous cyanobacterium; Fv, Fragaria vesca; Ga, 
Gossypium arboreum; Gm, Glycine max; Gs, Glycine soja; Ha, Halomonas alkaliantartica; 
Hs; Homo sapiens; Hv, Hordeum vulgare; Jc, Jatropha curcas; Ma, Microcystis aeruginosa; 
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Md, Malus domestica; Mm, Mus musculus; Mt, Medicago truncatula; Nn, Nelumbo 
nucifera; Ns Nicotiana sylvestris; Nt, Nicotiana tabacum; Ob, Oryza brachyantha; Os, 
Oryza sativa; Pan, Pseudanabaena sp. PCC 6802; Pe, Populus euphratica; Pt, Populus 
trichocarpa; Rc, Ricinus communis; Rs, Raphanus sativus; Sb, Sorghum bicolor; Sc, 
Saccharomyces cerevisiae; Sh, Saccharum hybrid; Si, Setaria italica; Sin, Sesamum 
indicum; Sl, Solanum lycopersicum; Syn, Synechocystis; Ta, Triticum aestivum, Td, 
Thiothrix disciformis; Th, Tarenaya hassleriana; Vr, Vigna radiata; Zm, Zea mays. The 
bootstrap values supporting each branch are in green color and a bootstrap value 
above 70% provides good support for the branch. (Figure from publication IV). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19. Comparison of the spermine binding mode of PAOs with different 
oxidation mode. (A) The X-ray structure of ZmPAO in complex spermine (PBD ID: 
3KU9, M300K mutated). (B) The homology model of SynPAO with the docked 
spermine. (C) The X-ray structure of yeast Fms1 in complex with spermine (PDB 
ID: 1XPQ; chain A). (D) The homology model of MmSMO with the docked 
spermine. FAD is shown in white sticks and spermine in yellow sticks (Figure 6 in 
publication IV). 
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Table 3. Residues from the Spermine binding site of PAOs that share branch II 
(Figure 18) with SynPAO compared with the residues in Fms1 and MmSMO. The 
highly conserved positions in plant and bacterial PAOs have orange and grey 
backgrounds, respectively. Residues positioning spermine are highlighted in 
yellow. The totally conserved residues in the branch II proteins (Figure 16) are 
shown in bold (Table  from publication IV). 
 
Residues in ZmPAO and Fms1 are numbered according to the crystal structures. 
Residues in SynPAO are numbered according to the sequence entry (UniProt 
Q6ZEN7) and MmSMO according to (Tavladoraki et al., 2011). 
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6. Conclusion  
 
This thesis describes the use of bioinformatics methods to 
characterize proteins from the amine oxidase family. Sequence 
analysis, molecular docking, homology modelling and phylogenetics 
were used as the methods and complemented with the results from 
the experimental studies to increase the reliability of the 
computational results. 
In publication I, evolutionary studies, sequence and structural data 
were used together to show that mammalian CAOs can be classified 
based on the active site motif (X1-X2-Asn-Tyr-Asp). X2 can be used 
to discriminate between AOC1 (X2=Tyr), AOC2 (X2=Gly) and 
AOC3/4 (X2=Leu), whereas residue X1 can be used to discriminate 
between AOC3 (X1=Leu) and AOC4 (X1=Met). The classification is 
consistent with the substrate preferences of these proteins. The 
revised classification rules can be used to correctly classify new 
CAO sequences and aid in the reclassification of wrongly annotated 
sequences.  Additionally, a third residue that seems to play a role in 
the substrate preference was found in the active site of mammalian 
CAOs, Asp186 in hAOC1, His206 in hAOC2, Thr212 in hAOC3, and 
Asn211 in bAOC4. Moreover, publication I also shows the species-
specific expression profile of CAOs, which means that not all 
mammals have the same number of CAOs and that when studying 
one specific CAO it is important to be aware of the other CAOs 
expressed in that organism.  
Publication II studies the N-glycosylation sites of hAOC1, in 
particular the N-glycosylation site conserved in mammalian CAOs 
(hAOC1Asn110). This conserved site is occupied by oligomannosidic 
glycans in hAOC1, pAOC1 and hAOC3. In these proteins, this site is 
located in a hydrophobic cleft that interacts with the core 
trisaccharide of the attached N-glycan. This site is the key for 
hAOC1 segregation, as it seems to be important for the correct 
folding of the D2 domain and, consequently, the folding of a 
functional hAOC1. Based on the conservation, it might have a 
similar role in mammalian CAOs. The other N-glycosylation sites in 
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hAOC1, located at Asn538 and Asn745, also seem to have an 
important structural role, stabilizing the inter-monomeric arms of 
the D4 domain.  Understanding the role of the carbohydrates for the 
half-life and clearance of hAOC1 is important, if recombinant AOC1 
is to be used in patients to degrade exogenous and endogenous 
histamine. For example, pAOC1 has been used in the treatment of 
several diseases with limited success (Laymon and Cumming, 1939). 
Knowing the glycan structures involved in hAOC1 clearance 
together with modern biotechnological methods, might help to 
circumvent the issues that arose decades ago when this therapy was 
first reported.  
In publication III, the interaction mode between hAOC3 and the 
Siglec-9 derived peptide was re-evaluated in the light of the new 
data. Understanding of atomic level interactions as well as the 
species-specific differences in the residues involved in the 
interactions is important for optimizing the peptide for the PET 
studies. The results obtained with the Siglec-9 derived peptides are 
consistent with the previous studies using the full-length 
extracellular region of Siglec-9. Thus, this study demonstrates that 
analysis of peptide-protein interactions can function as a good 
model for studying protein-protein interactions. Moreover, the 
Synechocystis sp. PCC 6803 PAO (SynPAO) was characterized in 
publication IV. The phylogenetic analysis together with structural 
data (docking and structural comparison) identified the key residues 
that play a role in spermine oxidase in SynPAO.  
The 3D coordinates alone give information about the shape of the 
protein, however, when relating them with other data, they provide 
valuable information on the type of fold and the functional 
classification of the protein. This demonstrates the importance of 
using an integrative approach of data analysis, which by connecting 
different bits of information from different sources, allows us to 
obtain biologically meaningful data and expand the understanding 
about various aspects of proteins. Proteins from amine oxidase 
family are widely distributed in the tree of life, and in general there 
is more than one member of this family present in each organism. 
Here the members of the amine oxidase protein family were 
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characterized using different bioinformatics methods and the results 
were analysed together with experimental data. The new 
classification rules for mammalian CAOs allow classifying correctly 
CAOs into their subfamily, and aid in the design of new subfamily 
specific inhibitors. The work with CAOs also will benefit the design 
of in vitro tests to detect individual CAO levels, that could be used 
for diagnostic purposes and to improve the current CAO-targeted 
drugs and biomarkers. The other amine oxidase member studied 
here PAO, also has a variety of potential applications. The 
knowledge obtained here can be used to understand the residues 
behind the substrate preference in PAOs and for example, to guide 
protein engineering to develop biosensors to detect biogenetic 
amines. As proteins from this family are used both as drug targets 
and biomarkers, and their role in different diseases is widely 
studied, the research presented in this thesis can be used to further 
develop the research in the amine oxidase family. Moreover, this 
thesis also shows that when used correctly bioinformatics can be 
successfully used to optimize different research projects. 
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